Get eListed!

SAN DIEGO, CA - August 14, 2026 (STL.News) Robbins Geller Rudman & Dowd LLP is a U.S. litigation law firm best known for representing investors, pension funds, and other plaintiffs in securities fraud class actions and complex corporate litigation. The firm frequently appears in litigation involving publicly traded companies, including cases alleging misleading financial statements, undisclosed business risks, accounting problems, and other violations of federal securities laws. For investors following securities class actions, however, it is important to distinguish among several different roles a law firm may play. Robbins Geller may investigate potential claims, issue an investor notice about an existing lawsuit, file a complaint on behalf of a client, represent a proposed lead plaintiff or ultimately receive court approval to serve as lead counsel. Those roles are not interchangeable. Robbins Geller has nevertheless established a substantial record in securities litigation. Independent settlement data published by Securities Class Action Services lists the firm as counsel in several of the largest securities class-action recoveries in U.S. history, including Enron, Household International, Valeant Pharmaceuticals, American Realty Capital Properties, UnitedHealth Group and Twitter. What is Robbins Geller Rudman & Dowd LLP? Robbins Geller Rudman & Dowd LLP, commonly referred to as Robbins Geller, is headquartered in San Diego and operates as a national plaintiffs' litigation firm. The firm's present-day organization grew from law practices with decades of experience representing shareholders and institutional investors. An important step in that history occurred in 2004, when Lerach Coughlin Stoia & Robbins acquired Geller Rudman, a firm then operating from offices in New York and Florida. The transaction expanded the securities litigation practice's presence on the East Coast. The organization subsequently evolved into what is now Robbins Geller Rudman & Dowd LLP. Independent litigation-ranking publication Benchmark Litigation reports that Robbins Geller has approximately 200 attorneys across 10 offices nationwide and handles matters extending beyond securities litigation into areas including antitrust, consumer protection and shareholder litigation. Robbins Geller Rudman & Dowd LLP - Securities fraud is a major part of the firm's practice Securities litigation is one of the areas in which Robbins Geller is best known. These cases commonly arise after a publicly traded company's stock price declines following disclosure of information that investors contend should have been disclosed earlier. A typical federal securities case may allege that a company or its executives made materially false or misleading statements, omitted important information, or otherwise violated provisions of the Securities Act of 1933 or the Securities Exchange Act of 1934. The existence of a stock-price decline does not by itself establish securities fraud. Plaintiffs generally must establish the legal elements applicable to their claims, and defendants have opportunities to challenge allegations through motions to dismiss, discovery, summary judgment, trial, and appeals. Robbins Geller represents investors on the plaintiff side of these disputes. Robbins Geller Rudman & Dowd LLP and the Enron securities litigation Perhaps the firm's best-known securities case is the litigation arising from the collapse of Enron Corp. Robbins Geller attorneys served as lead counsel representing investors, including the Regents of the University of California. The litigation ultimately resulted in settlements exceeding $7.2 billion for investors, according to court filings and settlement rankings. The recovery remains the largest securities class-action recovery listed by Securities Class Action Services. The case was extraordinarily complex. According to materials describing the litigation, attorneys reviewed tens of millions of pages of documents and conducted hundreds of fact depositions while pursuing claims against financial institutions and other defendants associated with Enron. The Enron result established Robbins Geller as one of the most prominent firms representing institutional investors in large securities cases. Robbins Geller Rudman & Dowd LLP - Household International produced $1.575 billion recovery Another significant Robbins Geller case involved Household International, later associated with HSBC Finance. Unlike many securities class actions that settle before trial, the Household litigation proceeded through a jury trial. A jury returned a securities fraud verdict for the investor class in 2009. Subsequent litigation and appellate proceedings continued for years before the case ultimately resulted in a $1.575 billion recovery. The litigation involved allegations concerning Household's lending practices, loan portfolio, and financial reporting. Securities Class Action Services ranks the Household recovery among the largest securities class-action settlements in U.S. history. The case is particularly notable because securities fraud class actions rarely reach a jury verdict. Robbins Geller Rudman & Dowd LLP - Twitter litigation resulted in $809.5 million recovery Robbins Geller also served as lead counsel in major securities litigation involving Twitter Inc., now known as X. The case resulted in an $809.5 million settlement for investors. Harvard Law School described the recovery in a 2026 program examining the litigation as the second-largest shareholder class-action settlement in the Ninth Circuit and one of the largest nationally. Robbins Geller partner Dan Drosman served as lead counsel in the litigation. The size of the Twitter settlement placed the case among Robbins Geller's most significant securities recoveries. Other major securities recoveries Independent securities settlement rankings identify Robbins Geller with numerous other substantial investor recoveries. Among those listed are: - Valeant Pharmaceuticals International — $1.21 billion - American Realty Capital Properties — $1.025 billion - UnitedHealth Group — $925.5 million - HealthSouth — approximately $804.5 million - Wachovia securities litigation — $627 million - Cardinal Health — $600 million - Countrywide Financial — $500 million These figures represent recoveries associated with particular litigation and should not be interpreted as guarantees of results in other cases. Court-related materials also identify Robbins Geller as sole lead counsel in the Cardinal Health litigation, which resulted in a $600 million recovery, and as co-lead counsel in litigation involving Wachovia securities that resulted in a $627 million settlement. Robbins Geller Rudman & Dowd LLP - The firm's work extends beyond completed cases Investors are also likely to encounter the Robbins Geller name much earlier in the litigation process. The firm routinely publishes notices concerning potential securities claims and pending class actions. Those notices may announce that Robbins Geller is investigating a company, that a securities lawsuit has been filed, or that investors have an upcoming deadline to seek appointment as lead plaintiff. For example, in July 2026 Robbins Geller announced that it had filed a securities class action involving GPGI Inc. in the U.S. District Court for the Southern District of New York. The case alleges violations of the Securities Exchange Act of 1934. The firm also filed a July 2026 securities action involving PicS N.V. and its January 2026 initial public offering. At the same time, Robbins Geller has issued notices concerning lawsuits it did not necessarily originate. This distinction is important when evaluating securities litigation announcements. Robbins Geller Rudman & Dowd LLP - Investigation does not mean a lawsuit has been filed One of the most important distinctions for investors is the difference between a law-firm investigation and a filed securities class action. When Robbins Geller or another securities firm announces an investigation, that generally means attorneys are evaluating whether potential claims exist and may be seeking information from shareholders. An investigation does not establish wrongdoing. It also does not necessarily mean a lawsuit will ultimately be filed. A filed class action is different. It involves an actual complaint submitted to a state or federal court that identifies plaintiffs, defendants, and legal claims. Even then, allegations remain allegations until established through a judgment or otherwise resolved. Robbins Geller Rudman & Dowd LLP - Issuing an investor notice does not mean the firm filed the case Investors should also be cautious about assuming that the law firm issuing a press release filed the underlying lawsuit. Multiple plaintiffs' firms routinely distribute announcements concerning the same securities class action. A firm may seek investors interested in becoming lead plaintiffs even when another law firm has filed the initial complaint. Consequently, STL.News distinguishes between firms that: - announce an investigation; - issue notices concerning an existing case; - file the original complaint; - represent a lead-plaintiff applicant; - are appointed by a court as lead or co-lead counsel; or - ultimately obtain a settlement or judgment. That distinction provides investors with a clearer understanding of a firm's actual involvement in a particular proceeding. What does lead counsel mean? The Private Securities Litigation Reform Act of 1995 created a process governing leadership of many federal securities class actions. After a securities class action is filed, investors typically receive notice of a deadline for seeking appointment as lead plaintiff. The court determines which applicant should serve as lead plaintiff under the applicable statutory standards. The lead plaintiff then selects counsel, subject to court approval. Being mentioned in an investor notice therefore does not automatically make a law firm lead counsel. Robbins Geller has, however, received court appointments as lead or co-lead counsel in major cases. Court-related materials document the firm's lead-counsel roles in litigation, including Enron and Cardinal Health. Robbins Geller Rudman & Dowd LLP - Why Robbins Geller frequently appears in investor news The firm's prominence in securities litigation means investors may encounter Robbins Geller announcements following substantial stock declines, earnings surprises, regulatory disclosures, accounting issues or other developments involving publicly traded companies. That does not mean every company identified in an investigation violated securities laws. Nor does the announcement of an investigation establish that litigation will be successful. Investor notices are also a way for plaintiffs' firms to identify shareholders who may have suffered losses and could potentially serve as plaintiffs. Readers should therefore examine the underlying court docket, complaint and company disclosures rather than relying exclusively on a law firm's announcement. Robbins Geller Rudman & Dowd LLP - Robbins Geller's broader litigation practice Although securities litigation is a major component of its public profile, Robbins Geller is not exclusively a securities law firm. Benchmark Litigation identifies the firm as having substantial work in antitrust, consumer protection, and shareholder litigation. The firm's reported results include litigation involving corporations and industries extending well beyond Wall Street and publicly traded securities. Still, securities class actions remain one of the principal areas in which investors are likely to encounter the Robbins Geller name. What investors should know about Robbins Geller Rudman & Dowd LLP? An investor who receives or encounters a Robbins Geller securities notice should first determine exactly what has occurred. Has the firm merely opened an investigation? Has somebody already filed a class-action complaint? Did Robbins Geller file that complaint? Is the firm seeking a shareholder to become lead plaintiff? Or has a court already appointed Robbins Geller as lead counsel? Those distinctions can substantially change the meaning of an announcement. Investors should also recognize that securities class actions can take years to resolve. Complaints can be amended or dismissed, defendants can prevail, cases can settle, and settlement amounts can differ significantly from claimed investor losses. Past results obtained by Robbins Geller or any other law firm do not guarantee a similar outcome in future litigation. Robbins Geller Rudman & Dowd LLP - About this STL.News law firm profile This profile is part of STL.News coverage of securities litigation and the law firms participating in investor class actions. The profile is independent editorial content and is not sponsored by Robbins Geller Rudman & Dowd LLP. The firm has not paid STL.News for inclusion or favorable coverage. Information is compiled from court-related records, independent litigation and settlement sources, public announcements, and information published by the firm. Statements describing a firm's own accomplishments are attributed accordingly when appropriate. STL.News intends these profiles to help readers understand who is participating in securities litigation and, importantly, the specific role a law firm plays in an individual case. Editorial Notice: This profile is provided for news and informational purposes only. STL.News does not endorse or recommend Robbins Geller Rudman & Dowd LLP or any other law firm mentioned in its coverage. Nothing in this article constitutes legal, investment, or financial advice. Past litigation results do not guarantee future outcomes. Read the full article

NEW YORK - August 13, 2026 (STL.News) Gildan Activewear Inc. (NYSE: GIL) remains the subject of multiple securities-law investigations following allegations by a short seller that raised questions about the apparel manufacturer's revenue growth, distributor inventory levels, and certain sales practices. Rosen Law Firm issued its latest investor notice Thursday, Aug. 13, saying it continues to investigate potential securities claims on behalf of Gildan shareholders. The firm said its investigation stems from allegations that Gildan Activewear may have provided materially misleading business information to investors. The Rosen announcement is the latest in a series of investor alerts issued since June, when a report from short seller Jehoshaphat Research triggered a sharp decline in Gildan shares and prompted several shareholder-rights firms to begin investigations. Importantly, the matter should not currently be confused with a filed securities class-action lawsuit. The notices reviewed for this report describe investigations into potential claims. Hagens Berman, for example, currently lists no class period and no lead-plaintiff deadline for its Gildan investigation. BFA appears to have announced an early investigation of Gildan Activewear A review of publicly available announcements shows that Bleichmar Fonti & Auld LLP, or BFA Law, announced an investigation into Gildan on the morning of June 17, one day after the short-seller report was released. BFA's announcement was published at 6:46 a.m. Eastern on June 17. The firm said it was investigating potential securities fraud, alleging that Gildan engaged in channel stuffing to artificially inflate revenue. That is earlier than several other June 17 announcements located during a review for this article. Block & Leviton announced its investigation later that morning. A Newsfile announcement timestamped 9:36 a.m. Eastern said the firm was investigating Gildan for potential securities-law violations following the June 16 stock decline. Levi & Korsinsky announced an investigation at 2:47 p.m. Eastern on June 17, according to its PR Newswire release. Based on the publicly available notices located and reviewed for this report, Bleichmar Fonti & Auld is the earliest law firm identified as publicly announcing a Gildan securities investigation following the June 16 short-seller report. That does not necessarily establish that BFA was the first firm to begin internal investigative work; it does establish that its June 17 announcement is the earliest public notice identified in this review. Short-seller report triggered Gildan stock plunge The investigations trace back to June 16, when Jehoshaphat Research disclosed a short position in Gildan and published a report challenging the company's reported organic growth and business practices. Jehoshaphat alleged that Gildan had been pushing excess merchandise into its distribution channel and estimated that approximately $510 million of unnecessary product was sitting in the channel during the first quarter of 2026. The short seller also alleged that Gildan's underlying organic growth had been weaker than its reported results suggested and questioned the company's use of receivables purchase arrangements and certain payment terms offered to distributors. These are allegations made by a short seller with a financial interest in a decline in Gildan's share price. They have not been established as facts by a court. The market reaction was nevertheless substantial. Gildan shares fell approximately 18.8% on June 16. One market report placed the NYSE closing price at approximately $50.34, down 18.77% for the session. Hagens Berman subsequently estimated that the decline erased approximately $2.15 billion from Gildan's market capitalization. The sharp one-day decline became the central event cited by law firms investigating whether investors may have securities claims. Gildan Activewear rejects implications of short-seller report Gildan responded to the allegations on June 16, the same day the report was published. The Montreal-based company said it was aware of the short-seller report and expressed confidence in the accuracy and completeness of its existing disclosures. Gildan said its disclosures provide investors with accurate and comprehensive information concerning the company, including its financial information and governance practices. It also reiterated the fiscal 2026 guidance it had issued April 30. The company said at the time that it did not intend to comment further. Gildan's response is significant because the allegations contained in the Jehoshaphat report remain disputed. Morningstar, in an analysis published June 16, also described the negative stock-market reaction as excessive while noting the risks raised by the short-seller report. Multiple firms investigating Gildan Since the June 16 decline, a growing group of shareholder-rights law firms has announced or continued investigations involving Gildan Activewear. Among the firms identified in publicly available notices are: - Bleichmar Fonti & Auld LLP — Announced an investigation June 17 into potential securities fraud involving the channel-stuffing allegations. - Block & Leviton LLP — Announced June 17 that it was investigating potential securities-law violations following the stock decline. - Levi & Korsinsky LLP — Announced an investigation June 17 and subsequently issued additional investor notices concerning Gildan. - Hagens Berman Sobol Shapiro LLP — Announced an investigation focused on whether the short seller's allegations are accurate and, if so, whether Gildan may have violated federal securities laws. - Pomerantz LLP — Announced July 7 that it was investigating whether Gildan and certain officers or directors engaged in securities fraud or other unlawful business practices. - Glancy Prongay Wolke & Rotter LLP — Continued an investigation in July concerning possible violations of federal securities laws. - Rosen Law Firm — Continues to investigate potential securities claims and issued its latest public investor notice on Aug. 13. Other shareholder-rights firms may also be reviewing the matter, and additional firms could become involved. What investigators are examining The investigations generally center on whether Gildan's statements to investors accurately reflected the condition of its business and distribution channel before the June 16 report. Jehoshaphat's central allegation involves what is commonly referred to as "channel stuffing" — pushing more products into distributors than underlying customer demand would otherwise justify, potentially pulling future sales into an earlier reporting period. The short seller alleged that certain customers were offered incentives or extended payment terms to encourage purchases near the end of reporting periods. It also questioned whether Gildan's organic growth was as strong as investors had been led to believe. Hagens Berman said its investigation focuses on whether Jehoshaphat's analysis is accurate and, if so, whether Gildan engaged in improper revenue recognition practices. Gildan, however, has stood behind its disclosures and financial reporting. That distinction is important. The existence of a law-firm investigation does not establish that securities laws were violated, nor does a short-seller report constitute a regulatory or judicial finding of wrongdoing. Gildan is a major global apparel manufacturer Gildan Activewear is headquartered in Montreal and manufactures a broad portfolio of basic apparel, including activewear, underwear, socks and intimates. Its brands include Gildan, Hanes, Comfort Colors, American Apparel, GOLDTOE, Peds, Bali, Playtex, Maidenform and Bonds. The company also operates under licensing arrangements involving other brands. Gildan operates large-scale vertically integrated manufacturing facilities, primarily in Central America, the Caribbean, North America and Asia. The company's scale increased substantially following its acquisition of HanesBrands, a transaction that expanded Gildan's exposure to consumer and innerwear markets. According to Gildan's 2025 shareholder report, activewear sales totaled approximately $3.09 billion for the year, up 9%, while innerwear sales increased 21%, primarily reflecting the HanesBrands acquisition. Investigation is not the same as a lawsuit Investors should distinguish between an investigation announcement and a securities class-action complaint filed in federal court. The notices reviewed for this article primarily solicit information from investors and announce investigations into whether potential securities claims exist. For example, Hagens Berman's Gildan investigation page currently lists both the class period and lead-plaintiff deadline as "N/A." By comparison, when a securities class action has actually been filed, investor notices generally identify the court case, alleged class period, and deadline for investors seeking appointment as lead plaintiff. No such conclusion should be drawn merely because a law firm's marketing notice uses terms such as "class action investigation." What comes next for Gildan investors The next phase will depend on what the investigating firms uncover and whether any investor ultimately files a complaint alleging violations of federal securities laws. A lawsuit would still involve allegations that must be proven in court. It would not establish wrongdoing by Gildan or its executives. For now, the central dispute remains between the claims presented in the June 16 Jehoshaphat Research report and Gildan's position that its existing financial and governance disclosures are accurate and comprehensive. Rosen's Aug. 13 announcement demonstrates that the legal review surrounding the June stock decline remains active nearly two months after the short-seller report first rattled investors. Editor's note: Securities-law investigations and short-seller allegations do not constitute findings of wrongdoing. Gildan Activewear has disputed the implications of the June 16 short-seller report and has stated that it is confident in the accuracy and comprehensiveness of its disclosures. Investors should conduct their own research and consult qualified financial or legal professionals when appropriate. This article is for informational purposes and is not investment or legal advice. Read the full article

OCEANSIDE, CA - August 13, 2026 (STL.News) Suja Life Inc. (NASDAQ: SUJA) is facing a growing number of securities-law investigations after the beverage company reduced its 2026 sales outlook and its stock plunged more than 46% in a single trading session, only months after completing its initial public offering. At least several shareholder-rights law firms have announced investigations into Suja Life following the company's Aug. 4 second-quarter financial report. The firms are examining whether Suja or certain executives may have violated federal securities laws or whether investors received materially misleading information. Importantly, these announcements concern investigations into potential securities claims. They should not be confused with a securities class-action lawsuit that has already been filed. As of Aug. 13, STL.News has not independently identified a federal securities class-action complaint filed against Suja arising from these allegations. The investigations followed an unusually sharp decline in Suja shares. The stock fell $5.27, or approximately 46.2%, to close at $6.14 on Aug. 5, according to information cited in investor notices issued following the company's earnings announcement. Holzer & Holzer Was Among the First to Announce Investigation Based on a review of publicly available investigation announcements, Holzer & Holzer LLC was among the first law firms to publicly announce a Suja Life investigation on Aug. 5, 2026, shortly after the company's stock decline. The Atlanta-based securities litigation firm announced that it was investigating whether Suja complied with federal securities laws. Its notice focused on the company's Aug. 4 financial results and updated fiscal 2026 outlook. However, multiple firms issued Suja investigation announcements on Aug. 5, and available publication timestamps do not establish with sufficient certainty that Holzer & Holzer was literally the first firm to initiate an investigation that day. The Law Offices of Frank R. Cruz and Rosen Law Firm also announced investigations dated Aug. 5. Accordingly, Holzer & Holzer can be accurately described as one of the earliest publicly identified firms investigating Suja, rather than definitively the first, without additional timestamp evidence. That distinction is important because none of the announcements establishes wrongdoing by Suja or its executives. Suja's Second-Quarter Results Trigger Investor Scrutiny The investigations center on Suja's Aug. 4 release of financial results for the quarter ended June 29. Suja reported second-quarter net sales of $83.9 million, an increase of 11.6% from $75.2 million during the comparable period a year earlier. The company attributed the increase primarily to volume growth across key products and retailers, as well as gains from new product distribution. Suja Core net sales increased 9.8% to $81.9 million, while Emerging Brands net sales increased 61.2% to $3 million. Those sales gains, however, were accompanied by a substantial quarterly loss. Suja reported that its net loss increased to approximately $27.8 million, compared with approximately $5.7 million in the prior-year period. Selling, general and administrative expenses totaled $59.7 million, including $25.1 million of one-time expenses associated with the company's IPO. The company also disclosed that it had $20.6 million in cash and $163 million in total debt as of June 29. That compared with $31 million in cash and $303.9 million in debt as of Dec. 29, 2025, before completion of the IPO. Suja Cuts 2026 Sales Outlook The portion of the earnings announcement drawing particularly close attention from plaintiffs' firms was Suja's revised full-year outlook. The company said it was updating its fiscal 2026 guidance to account for near-term softness concentrated in the grocery channel. Suja now expects net sales between $360 million and $369 million, representing anticipated growth of approximately 10.2% to 13% compared with fiscal 2025 net sales of $326.6 million. The company maintained expectations for adjusted EBITDA of $70 million to $72 million, representing growth of approximately 72.8% to 77.7% from $40.5 million in fiscal 2025. Johnson Fistel PLLP said the previous sales outlook had called for $367 million to $371 million. The firm also highlighted management's disclosure of weaker-than-expected bookings and product performance even as the company's total distribution points had increased. Investors reacted sharply. Suja shares dropped $5.27 on Aug. 5, closing at $6.14, a decline of approximately 46.18% in one session, according to the Law Offices of Frank R. Cruz investigation notice. Rosen Law Firm Opens Suja Investigation Rosen Law Firm is among the firms now investigating potential claims on behalf of Suja shareholders. The New York-based investor-rights firm said it is examining allegations that Suja may have issued materially misleading business information to investors. Rosen initially announced its investigation on Aug. 5 and subsequently issued additional investor notices, including one on Aug. 13. The firm's language is significant. Rosen is investigating potential securities claims; its announcement does not establish that Suja committed securities fraud. An investigation by a plaintiffs' securities firm can precede a lawsuit, but an investigation does not necessarily result in litigation. Other Law Firms Investigating Suja Life The number of firms examining Suja has continued to increase since the Aug. 4 earnings announcement. Publicly announced investigations include: - Holzer & Holzer LLC — Announced Aug. 5 that it was investigating whether Suja complied with federal securities laws following the company's financial results and revised outlook. - The Law Offices of Frank R. Cruz — Announced Aug. 5 that it was investigating Suja on behalf of investors concerning possible violations of federal securities laws. The firm's announcement cited the increase in Suja's quarterly net loss, the revised outlook, and the subsequent 46.18% stock decline. - Rosen Law Firm — Announced Aug. 5 that it was investigating potential securities claims arising from allegations that Suja may have provided materially misleading business information to investors. Rosen has since issued additional notices concerning the investigation. - Johnson Fistel PLLP — Announced its investigation Aug. 7, focusing on the reduced sales guidance, weaker-than-expected bookings and questions about whether Suja or certain executives may have violated state or federal securities laws. - Hagens Berman Sobol Shapiro LLP — Announced an investigation Aug. 12 concerning potential federal securities-law violations following Suja's May IPO and subsequent decline in its share price. Other shareholder-rights firms have also circulated notices concerning Suja, reflecting increased legal scrutiny following the company's earnings report. Suja Went Public Only Three Months Earlier The timing of the stock decline is particularly notable because Suja had completed its IPO only a few months earlier. Suja entered into its IPO underwriting agreement on May 6 with Goldman Sachs & Co. LLC, Jefferies LLC and William Blair & Company LLC acting as representatives of the underwriters, according to an SEC filing. The company sold approximately 8.9 million shares of Class A common stock at $21 per share, raising approximately $173 million in capital after underwriting discounts and commissions, according to information cited by Hagens Berman in its investigation. That $21 IPO price provides important context for investors. At the Aug. 5 closing price of $6.14, Suja shares were approximately 71% below the IPO price less than three months after the offering. That post-IPO decline has become a central element in the investigations conducted by some shareholder firms. Suja Had Reported Strong First-Quarter Performance The second-quarter development also followed stronger results earlier in the year. For the first quarter ended March 30, Suja reported net income of $7.7 million, compared with a net loss of approximately $800,000 during the comparable prior-year period. Adjusted EBITDA increased 66.3% to $25 million from $15 million. Suja Core adjusted EBITDA increased 43.4% to $26.9 million, while the adjusted EBITDA loss for Emerging Brands narrowed to $1.9 million from $3.7 million. That earlier performance provides additional context for the market's reaction when Suja subsequently disclosed softness in portions of its business and reduced its full-year sales expectations. What the Investigations Mean for Suja Investors Securities law firms commonly begin investigations following sharp stock declines associated with earnings announcements, revised financial guidance, regulatory disclosures, or other significant corporate developments. Investigators may review SEC filings, earnings calls, registration statements, investor presentations and statements made by company executives to determine whether investors were adequately informed about material business risks. The existence of such an investigation does not mean securities fraud occurred. For Suja, the inquiry could include statements made regarding the company's IPO, subsequent financial disclosures, expectations for sales growth, grocery-channel performance, bookings, and the timing of the company's revised outlook. Whether any firm ultimately files a securities class-action complaint remains to be seen. No Finding of Securities Fraud Against Suja Investors should distinguish between allegations contained in law-firm investigation notices and established facts. Suja has not been found liable for securities fraud based on the investigations discussed in this report. An investigation by a private plaintiffs' law firm is not a determination by a court, the Securities and Exchange Commission or another regulator that a company violated securities laws. Likewise, the sharp decline in a company's share price following disappointing financial news does not by itself establish securities fraud. To prevail in a federal securities-fraud case, plaintiffs generally must establish additional elements, including a materially false or misleading statement or omission and other requirements under applicable securities laws. For now, Suja remains the subject of multiple investor investigations rather than a confirmed securities class-action lawsuit arising from the Aug. 4 disclosure. The central facts are nevertheless significant: Suja completed its IPO in May at $21 per share, reported its second-quarter results and lowered its sales outlook on Aug. 4, and watched its stock fall more than 46% the following trading day. Within hours of that decline, shareholder law firms began publicly announcing investigations. Holzer & Holzer was among the earliest firms identified in STL.News' review, issuing its investigation announcement on Aug. 5, alongside other same-day investigations from Rosen Law Firm and the Law Offices of Frank R. Cruz. Additional firms have since joined the scrutiny, increasing attention on what Suja disclosed to investors before and after its recent IPO. Disclaimer: This article is for informational and news-reporting purposes only and does not constitute legal, investment, or financial advice. Law-firm investigations and allegations do not establish wrongdoing, and no court has determined that Suja Life Inc. or its executives committed securities fraud in connection with the matters described above. Read the full article

SAN DIEGO, CA - August 13, 2026 (STL.News) Capricor Therapeutics, Inc. (NASDAQ: CAPR) is facing a new federal securities class action alleging that the biotechnology company and its leadership made materially false or misleading statements concerning the regulatory prospects for deramiocel, its investigational cell therapy for Duchenne muscular dystrophy. The lawsuit, Nkamga v. Capricor Therapeutics, Inc., et al., Case No. 3:26-cv-04385, was filed in the U.S. District Court for the Southern District of California on behalf of investors who purchased or otherwise acquired Capricor securities between Dec. 17, 2025, and July 26, 2026, inclusive. Importantly, the law firm that filed the original lawsuit in this current matter was Glancy Prongay Wolke & Rotter LLP, or GPWR. The firm's July 30 announcement states that it filed the class action on behalf of Capricor investors. Court docket information identifies investor Darren Ngasseu Nkamga as the named plaintiff and shows that he is represented by attorneys from Glancy Prongay Wolke & Rotter. Since that initial filing, numerous other securities law firms have issued notices concerning the case, sought potential lead plaintiffs or announced investigations related to Capricor. Investors currently have until Sept. 28, 2026, to ask the court to appoint them lead plaintiff in the action, according to multiple notices, including an Aug. 13 announcement from Rosen Law Firm. Glancy Prongay Wolke & Rotter Filed Lawsuit The distinction between the firm that filed the case and firms subsequently advertising the case to investors is significant. Glancy Prongay Wolke & Rotter announced July 30 that it had filed Nkamga v. Capricor Therapeutics, Inc., et al. The lawsuit seeks to represent investors who acquired Capricor securities during the Dec. 17, 2025-July 26, 2026 class period. The plaintiff asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. The federal docket identifies Nkamga as the plaintiff and Capricor Therapeutics and its Chief Executive Officer, Linda Marbán, as defendants. The lawsuit remains in its early stages. Its allegations have not been proven, no class has been certified, and the filing of the complaint does not constitute a finding that Capricor or any individual defendant violated federal securities laws. Lawsuit Centers on Deramiocel Disclosures At the heart of the dispute is Deramiocel, formerly known as CAP-1002, Capricor's investigational cell therapy being developed for patients with Duchenne muscular dystrophy, or DMD. Duchenne muscular dystrophy is a serious genetic disease characterized by progressive muscle degeneration and weakness. Deramiocel is an allogeneic cell therapy manufactured using donor heart tissue. Capricor has devoted substantial resources to developing Deramiocel and pursuing U.S. Food and Drug Administration approval. According to allegations described in the Rosen Law Firm notice, the defendants failed to adequately disclose that Capricor had changed the pre-specified statistical analysis plan used to analyze clinical data for Deramiocel, and that the FDA had not agreed to those changes before Capricor resubmitted its Biologics License Application. The complaint further alleges that these circumstances created a significant risk that the FDA could determine that the clinical results failed to provide substantial evidence of Deramiocel's effectiveness, thereby jeopardizing regulatory approval. Those assertions are allegations contained in the litigation and should not be interpreted as established facts or findings by the court. FDA Documents Triggered Sharp CAPR Selloff The litigation followed a dramatic change in investor expectations surrounding deramiocel. On July 27, 2026, the FDA released briefing materials ahead of a July 29 advisory committee meeting concerning Capricor's Biologics License Application. The materials raised questions about whether the company's submitted evidence was sufficient to demonstrate effectiveness. Capricor shares subsequently declined sharply as investors reassessed the likelihood of regulatory approval. The selloff wiped out a substantial portion of the company's market value and became the central loss event cited in shareholder litigation and law-firm investigations. The regulatory concerns did not end with the release of the briefing documents. On July 29, an FDA advisory panel concluded that Capricor had not definitively demonstrated that its experimental therapy benefits patients with heart-related complications from Duchenne muscular dystrophy. For a biotechnology company whose valuation is heavily influenced by the prospects of a key experimental therapy, developments at the FDA can cause unusually large changes in share price. What the Capricor Lawsuit Alleges The current complaint alleges, among other things, that investors were not adequately informed about regulatory risks associated with the deramiocel application. According to descriptions of the complaint, the plaintiff alleges that defendants made materially false or misleading statements or failed to disclose information concerning: - Changes allegedly made to the pre-specified statistical analysis plan for deramiocel clinical data. - The allegation that the FDA had not agreed to those changes before the company resubmitted the BLA. - The risk that regulators could determine the clinical evidence did not provide substantial evidence of effectiveness. - The resulting risk to FDA approval of deramiocel for Duchenne muscular dystrophy. - Whether positive statements concerning Capricor's business, operations, and prospects had a reasonable basis. The plaintiff claims investors suffered damages when information concerning those issues became known to the market. Capricor and the individual defendants will have the opportunity to contest the allegations and present their defenses as the litigation proceeds. Multiple Law Firms Focus on Capricor Investors A growing number of shareholder-rights firms have publicized the litigation or related investigations since Capricor's stock decline. Among the firms that have issued notices or are examining potential claims involving CAPR investors are: - Glancy Prongay Wolke & Rotter LLP — filed the current Nkamga securities class action in federal court. - Rosen Law Firm — issued an Aug. 13 notice concerning the pending class action and Sept. 28 lead plaintiff deadline. - Hagens Berman Sobol Shapiro LLP — has announced an investigation into Capricor following the July 27 disclosures and stock decline. - Block & Leviton LLP — announced an investigation into potential securities law violations involving Capricor. - Bleichmar Fonti & Auld LLP has announced an investigation into potential securities fraud claims involving Capricor investors. - Kirby McInerney LLP — has previously issued Capricor investor notices and is active in shareholder securities litigation involving the company. - Bernstein Liebhard LLP — has issued investor-related notices concerning securities class actions. - Law Offices of Frank R. Cruz — has been active in investigating potential shareholder claims. - Holzer & Holzer LLC — has publicized securities investigations on behalf of investors. - Law Offices of Howard G. Smith — has issued notices involving potential securities claims by shareholders. Investors should understand that the existence of multiple law-firm notices does not mean multiple independent lawsuits necessarily have been filed over the same allegations. Firms frequently announce investigations or solicit potential clients after a securities class action has already been filed. In this instance, Glancy Prongay Wolke & Rotter is the firm identified as having filed the original Nkamga complaint underlying the current Dec. 17, 2025-July 26, 2026 class period. An Earlier Capricor Securities Case Is Separate Capricor has also faced an earlier securities class action, and the two matters should not be confused. Capricor disclosed in a regulatory filing that, on July 17, 2025, a putative securities class action was filed in the Southern District of California naming Capricor and its CEO, Linda Marbán, as defendants. That earlier action alleged violations of federal securities laws and sought unspecified damages. Law-firm notices concerning that earlier litigation identify a class period running from Oct. 9, 2024 through July 10, 2025. That is distinct from the newly filed Nkamga action, which concerns investors who acquired CAPR securities from Dec. 17, 2025 through July 26, 2026. Keeping those cases separate is important because the alleged misconduct, class periods, market events, and procedural deadlines differ. September 28 Lead Plaintiff Deadline Investors covered by the current Nkamga lawsuit have until Sept. 28, 2026, to move the court for appointment as lead plaintiff, according to the Rosen and GPWR notices. The lead plaintiff generally represents the proposed investor class and works with court-appointed lead counsel to direct the litigation. An investor does not necessarily have to become lead plaintiff to potentially participate in a future recovery. Rosen's notice states that investors may retain counsel of their choosing or remain absent members of the proposed class, and that no class has yet been certified. There is also no guarantee that the litigation will produce a settlement or judgment for shareholders. Capricor's Regulatory Story Remains Central Beyond the shareholder litigation, the underlying FDA process surrounding deramiocel remains particularly important to Capricor. The company describes itself as a biotechnology company focused on developing transformative cell- and exosome-based therapeutics, with Duchenne muscular dystrophy representing a major focus of its development program. The FDA's concerns and subsequent advisory committee review therefore represented far more than a routine regulatory development. They affected expectations surrounding one of the company's most important potential products and prompted a rapid reassessment of CAPR's valuation by investors. The securities case will now examine a different question: whether investors received materially accurate and complete information about those regulatory risks during the alleged class period. That question will ultimately be determined through the federal court process, not through the allegations contained in shareholder law-firm announcements. For CAPR shareholders, the immediate procedural date to watch is Sept. 28, 2026, the deadline currently identified for investors seeking appointment as lead plaintiff in the newly filed class action. Disclaimer: This article is for news and informational purposes only and does not constitute legal or investment advice. The claims described in the securities lawsuit are allegations that have not been proven. Capricor Therapeutics and the individual defendants are presumed not liable unless liability is established through the judicial process. No class has been certified, and there has been no court determination that the defendants violated federal securities laws. Read the full article

TEMPE, AZ - August 13, 2026 (STL.News) First Solar Inc. (NASDAQ: FSLR) investors who purchased or acquired the company's securities during a roughly one-year period have until Aug. 24 to seek appointment as lead plaintiff in a federal securities class action alleging the solar manufacturer and certain executives made materially false or misleading statements about the effects of U.S. tariff policy on its operations. The lawsuit covers investors who purchased or otherwise acquired First Solar securities between Feb. 26, 2025, and Feb. 24, 2026, inclusive. The action is pending in the U.S. District Court for the Eastern District of New York under case number 26-cv-03787. The complaint seeks damages under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Securities and Exchange Commission Rule 10b-5. The allegations have attracted significant attention from securities litigation firms as the Aug. 24 lead plaintiff deadline approaches. Rosen Law Firm issued another investor notice Thursday, while numerous other firms have published notices concerning the same First Solar class action. The lawsuit's allegations have not been proven in court. First Solar and the individual defendants are entitled to contest the claims, and the filing of a securities lawsuit does not establish that the company or its executives violated federal securities laws. What the First Solar lawsuit alleges At the center of the litigation are allegations concerning First Solar's representations about its ability to manage the consequences of U.S. tariff policy and its international manufacturing operations. According to the complaint notices, the plaintiffs allege that First Solar overstated its ability to manage the impact of U.S. tariffs on its business. The complaint further alleges the defendants understated the extent to which First Solar's responses to tariff policy — including intentionally underutilizing manufacturing facilities in Malaysia and Vietnam and attempting to shift production to the United States — could negatively affect the company's projected financial performance during fiscal 2026. The plaintiffs contend that, because of those alleged omissions or misrepresentations, certain positive statements concerning First Solar's business, operations and prospects were materially misleading or lacked a reasonable basis. Those assertions represent the plaintiffs' allegations and should not be interpreted as established facts or findings by the court. January analyst downgrade figures in allegations One development highlighted by firms publicizing the litigation occurred on Jan. 7, when Jefferies downgraded First Solar from Buy to Hold. According to Glancy Prongay Wolke & Rotter LLP's description of the case, the analyst cited developments during 2025, including lowered guidance, significant debookings, and margin compression. The lawsuit ultimately encompasses a class period beginning Feb. 26, 2025, and ending Feb. 24, 2026. The latter date is particularly significant because First Solar released its fourth-quarter and full-year 2025 financial results and its 2026 financial guidance on Feb. 24. The company's financial disclosures and statements made throughout the class period are therefore important to the litigation as attorneys examine what investors were told, when information became publicly available, and how First Solar's stock responded. First Solar reports new 2026 financial results The securities litigation is unfolding while First Solar continues operating as one of the most prominent U.S. solar manufacturers. On Aug. 12, the company reported its second-quarter 2026 financial results and reaffirmed its full-year guidance. First Solar maintained projected 2026 net sales of $4.9 billion to $5.2 billion, gross profit of $2.4 billion to $2.6 billion, and adjusted EBITDA of $2.6 billion to $2.8 billion. The company also maintained expected sales volume of 17.0 gigawatts to 18.2 gigawatts and projected year-end net cash of approximately $1.7 billion to $2.3 billion. Those current results are separate from the allegations in the securities lawsuit, which concern statements and events associated with the specified class period from Feb. 26, 2025, through Feb. 24, 2026. First Solar stock remains volatile First Solar shares have experienced substantial volatility as investors weigh the company's earnings, federal trade policy, solar industry conditions, and other developments. FSLR closed Thursday, Aug. 13, at approximately $223.69, according to historical market data, after opening at $223.51 and trading between approximately $221.26 and $227.99 during the session. About 2.1 million shares changed hands. That followed an Aug. 12 close of $226.77. Earlier this week, First Solar shares closed Aug. 10 at $239.33, down 4.29% for the session. At that point, the stock remained well below its reported 52-week high of $320.95 reached June 3. The stock has also responded sharply to developments that investors view as favorable to domestic solar manufacturing. Recent U.S. trade measures involving imported polysilicon and solar products triggered significant moves in solar-sector shares, including First Solar. Analysts have also recently reassessed the company's outlook in response to tariff and trade-policy developments. Stock movements alone do not prove any of the allegations in the securities litigation. Establishing securities fraud generally requires plaintiffs to satisfy multiple legal elements, including requirements concerning material misstatements or omissions, reliance, loss causation and damages. Numerous law firms alert First Solar, investors The Rosen Law Firm notice issued Aug. 13 is one of numerous investor alerts associated with the First Solar litigation. Law firms that have issued notices, opened investigations or solicited First Solar investors concerning the litigation include: - Rosen Law Firm — issued the Aug. 13 notice reminding investors about the pending lead plaintiff deadline. - Pomerantz LLP — announced the filing of the First Solar class action and previously investigated potential claims involving the company. - Levi & Korsinsky LLP / SueWallSt — has reminded investors of the Aug. 24 lead plaintiff deadline and is seeking information from investors who sustained losses. - Faruqi & Faruqi LLP — is investigating potential claims and reminding investors about the pending federal class action and Aug. 24 deadline. - Glancy Prongay Wolke & Rotter LLP — has issued notices concerning the lawsuit and lists the Feb. 26, 2025, through Feb. 24, 2026, class period. - The Schall Law Firm — has published multiple notices encouraging affected First Solar investors to contact the firm before the deadline. - The Gross Law Firm — has issued notices to investors regarding the pending class action and Aug. 24 deadline. - Bronstein, Gewirtz & Grossman LLC — has notified investors about the class action and the deadline for requesting appointment as lead plaintiff. - Kaplan Fox & Kilsheimer LLP — issued an Aug. 13 notice reminding investors of the class action and Aug. 24 deadline. - Holzer & Holzer LLC issued an investor alert following the filing of the shareholder class action, summarizing allegations concerning First Solar's tariff exposure and business operations. The presence of multiple firms does not mean that multiple separate class actions necessarily will proceed independently. Securities cases involving substantially similar allegations can be consolidated, and the court ultimately determines the appointment of lead plaintiff and lead counsel. Investors should also understand that law-firm announcements are generally attorney advertising and are intended in part to identify potential clients. What the Aug. 24 deadline means The Aug. 24 deadline applies to investors seeking appointment as lead plaintiff. A lead plaintiff is generally an investor or group of investors appointed by the court to represent the proposed class and oversee the litigation on behalf of other class members. An investor does not automatically become lead plaintiff simply by contacting one of the law firms issuing notices. Interested investors must make the appropriate application to the court, and the judge determines who will serve in that role under the requirements governing federal securities class actions. Importantly, an eligible investor generally does not have to seek appointment as lead plaintiff to potentially participate in a future recovery. Notices from firms involved in the First Solar matter specifically state that investors may choose to take no action and remain absent members of the proposed class. The class also has not necessarily received final certification merely because a complaint has been filed. First Solar has a major U.S. manufacturing footprint First Solar is a Tempe, Arizona-based solar technology and manufacturing company specializing in advanced thin-film photovoltaic modules. The company has invested heavily in expanding U.S. manufacturing. According to First Solar's 2025 annual report, its U.S. annual nameplate manufacturing capacity grew from approximately 6 gigawatts in 2020 to approximately 13 gigawatts in 2025. The company projected that capacity would exceed 17 gigawatts annually by 2027. That domestic manufacturing footprint has become particularly significant as U.S. policymakers use tariffs, tax incentives and industrial policy to encourage domestic solar manufacturing and reduce dependence on overseas supply chains. First Solar also operates manufacturing facilities outside the United States, including operations in Malaysia and Vietnam — facilities that figure prominently in the allegations contained in the shareholder complaint. The company's scale helps explain why changes in tariff policy can have complicated effects. Trade protections may improve the competitive position of domestically manufactured solar products while simultaneously affecting overseas manufacturing, costs, supply chains and decisions about where production takes place. First Solar previously disclosed tariff-related risks First Solar's regulatory filings have long included extensive discussion of government policy and regulatory risks. Its 2025 annual report and Form 10-K address risks associated with tax incentives, trade policy, manufacturing, and other government actions that could affect the company's financial results. The company's SEC filing also discusses financial benefits associated with tax incentives and warns that results could be adversely affected if those benefits differ materially from company assumptions. The existence of risk disclosures does not by itself resolve the allegations in the pending lawsuit. A central question in securities litigation is often whether investors received adequate disclosure of known material risks and developments at the relevant time, rather than simply whether a company generally warned that adverse events might occur. Those issues will ultimately depend on the evidence, applicable securities law, and rulings by the federal court. Case remains at an early stage The First Solar lawsuit remains an active federal securities case, and the upcoming lead-plaintiff deadline is an early procedural milestone rather than a determination of liability. Following the Aug. 24 deadline, the court can consider competing motions from investors seeking appointment as lead plaintiff. Later stages could include the appointment of lead counsel, consolidation of related cases, if applicable, an amended complaint, motions to dismiss, discovery, and potentially class-certification proceedings. Securities cases can take years to resolve and may end through dismissal, settlement, trial or other court action. For now, investors should distinguish carefully between allegations contained in the complaint and findings made by a court. No court determination cited in the available materials establishes that First Solar or its executives committed securities fraud, and the defendants will have opportunities to challenge the allegations through the federal judicial process. For investors who purchased First Solar securities between Feb. 26, 2025, and Feb. 24, 2026, the immediate procedural date is Aug. 24, 2026, when the period for seeking appointment as lead plaintiff is scheduled to expire. Investor notice: This article is for news and informational purposes only and does not constitute legal, financial, or investment advice. The claims described above are allegations contained in pending litigation and law-firm notices. They have not been proven, and the filing of a lawsuit does not establish liability or wrongdoing. Investors should independently evaluate their circumstances and consult qualified legal or financial professionals when appropriate. Read the full article

SALT LAKE CITY, Utah - August 13, 2026 (STL.News) Myriad Genetics Inc. (NASDAQ: MYGN) is facing multiple shareholder investigations after the genetic testing company reported weaker second-quarter results, sharply reduced its 2026 revenue outlook and saw its stock lose nearly half its value following the announcement. Several shareholder-rights law firms have announced investigations concerning Myriad Genetics, including Kirby McInerney LLP, Levi & Korsinsky LLP, Schall, Brown & Schwartz LLP and Bragar Eagel & Squire P.C. Other firms have previously announced investigations involving Myriad and earlier company disclosures. The investigations generally seek to determine whether Myriad Genetics or its management made materially false or misleading statements, failed to disclose material information to investors, or otherwise violated federal securities laws. The announcements are investigations, however, and should not be confused with findings of wrongdoing. No determination that Myriad Genetics or its executives violated federal securities laws is established by the law firms' announcements. Myriad Genetics reports lower Q2 revenue The latest wave of investor scrutiny follows Myriad Genetics' second-quarter 2026 financial results. On July 30, Myriad reported quarterly revenue of approximately $190.7 million, representing an 11% decline from the comparable period a year earlier. Test volume declined approximately 1% year over year, while average revenue per test decreased approximately 9%. The company also disclosed an $11 million reduction in revenue related to changes in estimates of cash collections involving tests for which performance obligations had been satisfied in prior periods. Results differed across Myriad's operating categories. Cancer Care Continuum revenue was $114.1 million, down 11% from $127.7 million in the year-earlier period, even as testing volume increased. Prenatal Health revenue declined 16% to $39.8 million, accompanied by lower testing volume. Mental Health revenue totaled $36.8 million, representing a 3% year-over-year decrease. GeneSight testing volume increased, but average revenue per test declined. The combination of weaker revenue, reimbursement pressures, and collection issues became particularly important to investors given the impact on the company's financial outlook. Myriad cuts 2026 revenue guidance Myriad had reiterated its full-year 2026 revenue outlook of $860 million to $880 million in May. Following the second-quarter results, the company reduced that forecast to approximately $770 million to $790 million. The reduction lowered both ends of the range by approximately $90 million. Myriad also reduced its adjusted gross-margin outlook and suspended its previously issued adjusted EBITDA guidance. That guidance had called for adjusted EBITDA of approximately $37 million to $49 million. The magnitude and timing of the revised outlook have become central issues cited by several of the law firms investigating potential shareholder claims. Levi & Korsinsky, for example, pointed out that Myriad reiterated the $860 million to $880 million revenue range on May 5, only to reduce it by roughly $100 million three months later. The firm also cited Myriad's first-quarter Form 10-Q, which reported trade accounts receivable of $123.8 million as of March 31, compared with $115.3 million at the end of 2025. MYGN shares plunge following announcement Investors reacted sharply to the second-quarter report. Myriad Genetics shares closed at $5.37 on July 30 before plunging the following trading day. Kirby McInerney said MYGN declined $2.51, or approximately 47%, to close at $2.86 on July 31. The dramatic decline resulted in substantial losses for shareholders and quickly attracted attention from securities litigation firms. Large one-day stock declines do not by themselves demonstrate securities fraud. Plaintiffs' firms commonly investigate significant corporate disclosures and subsequent market declines to determine whether investors received materially misleading information before the disclosure. Whether sufficient evidence exists to support a securities claim is a separate legal question. Multiple firms investigate Myriad Genetics At least several shareholder-rights firms have announced investigations into Myriad Genetics, with several specifically focusing on the company's recent second-quarter results and revised guidance. The firms include: - Kirby McInerney LLP — The New York-based firm is investigating potential claims against Myriad Genetics concerning whether the company or members of senior management may have violated federal securities laws or engaged in other unlawful business practices. Its investigation specifically cites the July 30 second-quarter results, the 11% revenue decline, reduced 2026 guidance, and a $11 million revenue adjustment. - Levi & Korsinsky LLP — The firm has announced an investigation concerning potentially materially false or misleading statements involving Myriad. Its investigation highlights the company's May 2026 reaffirmation of expected revenue of $860 million to $880 million, followed approximately three months later by a reduction to $770 million to $790 million. It also points to the suspension of adjusted EBITDA guidance and to Myriad's accounts receivable position. - Schall, Brown & Schwartz LLP — SBS announced in August that it is investigating claims on behalf of Myriad Genetics investors for possible violations of securities laws. The firm said its investigation focuses on whether the company issued false or misleading statements or failed to disclose information pertinent to investors. - Bragar Eagel & Squire P.C. — The shareholder-rights firm has also announced an investigation concerning Myriad Genetics. Its announcement cites the July 30 second-quarter results, including approximately $190.7 million in revenue, as well as the company's revised full-year financial outlook. Other securities firms have investigated Myriad Genetics in connection with earlier company disclosures. Glancy Prongay & Murray LLP announced an investigation in May 2025 into possible violations of federal securities laws following Myriad's release of financial results and revision of its outlook. The Law Offices of Frank R. Cruz also previously announced an investigation on behalf of Myriad investors concerning possible violations of federal securities laws. Portnoy Law Firm announced in April 2026 that it had initiated an investigation into possible securities fraud involving Myriad Genetics and said it might file a class action on behalf of investors. Because the investigations were initiated at different times and in response to different company disclosures, investors should not assume that every law firm is examining an identical set of facts, time period or potential claim. Reimbursement issues draw scrutiny The company's reimbursement environment is particularly important to the current investigations. According to disclosures from the investigating firms, revenue from hereditary cancer testing declined even as testing volume increased. Myriad attributed pressure on revenue to factors including reimbursement rates and changes in estimates related to collections. The company has also discussed changing prior-authorization requirements, requests for additional medical records, and payer denial rates. These issues matter because diagnostic testing companies depend not only on the number of tests performed but also on their ability to obtain reimbursement from insurers and other payers. A company can therefore experience increasing testing volume without producing corresponding revenue growth if reimbursement per test declines or if collection rates deteriorate. That dynamic was visible in portions of Myriad's second-quarter results. What the investigations mean A shareholder investigation is an early-stage legal process and is different from a securities class-action lawsuit. Law firms may interview investors, review Securities and Exchange Commission filings, examine earnings releases and conference call statements, compare prior guidance with subsequent results, and investigate whether information material to investors should have been disclosed earlier. Following that review, a firm may determine that sufficient grounds exist to pursue litigation. It may also determine that a lawsuit is not warranted. Consequently, announcements from shareholder law firms requesting investors to provide information should not be interpreted as evidence that Myriad Genetics committed securities fraud. The investigating firms bear responsibility for the allegations contained in their respective announcements, and any allegations ultimately raised in litigation would have to be established through the judicial process. Myriad continues business initiatives Myriad Genetics continues to operate its diagnostic testing businesses while addressing the financial challenges disclosed in its second-quarter results. The company reported growth in testing volume in parts of its Cancer Care Continuum business and has continued to develop and commercialize products across oncology, women's health, and mental health. Myriad also highlighted initiatives aimed at improving operating efficiency, productivity, and scalability. The Salt Lake City-based company develops molecular diagnostic tests that provide genetic information to help patients and healthcare professionals assess disease risk and make treatment decisions. Its portfolio includes products associated with hereditary cancer risk, oncology, prenatal health and mental health. Investors await next developments The central question for shareholders now extends beyond the legal investigations. Investors will be watching whether Myriad can stabilize reimbursement, improve collections and average revenue per test, and deliver revenue within its newly reduced $770 million to $790 million 2026 range. The company's ability to address the factors behind the $11 million revenue adjustment will also be closely watched in subsequent financial reports. Meanwhile, the number of shareholder firms examining Myriad means additional legal announcements could follow. For now, the distinction between an investigation and litigation remains critical. Kirby McInerney, Levi & Korsinsky, Schall, Brown & Schwartz, and Bragar Eagel & Squire are among the firms investigating potential claims arising from recent developments at Myriad Genetics. Other firms have conducted investigations involving earlier disclosures. The existence of these investigations does not establish that Myriad Genetics, its officers, or its directors violated securities laws, and the allegations under investigation have not been proven in court. Disclaimer: This article is provided for news and informational purposes only and does not constitute investment or legal advice. Shareholder-investigation announcements represent statements by the respective law firms and should not be interpreted as findings of liability or wrongdoing. Read the full article

TAMPA, FL - August 13, 2026 (STL.News) Yuniel Lima-Santos, a 31-year-old Cuban national living in Tampa, pleaded guilty Thursday to multiple federal charges stemming from what prosecutors describe as an international operation that smuggled Cuban nationals into the United States, submitted fraudulent immigration applications, and moved proceeds through financial transactions and a shell company. Lima-Santos pleaded guilty to nine federal counts, including conspiracy to commit alien smuggling for financial gain, five counts of alien smuggling for financial gain, conspiracy to defraud the United States, conspiracy to launder monetary instruments and conspiracy to conceal money laundering instruments, according to the U.S. Department of Justice. He faces a maximum penalty of 20 years in federal prison. A sentencing hearing has not yet been scheduled. The guilty plea represents another conviction in a sprawling federal investigation involving 12 defendants and an organization prosecutors say encouraged or induced thousands of Cuban nationals to enter the United States through the southern border or through fraudulent use of the Electronic System for Travel Authorization, known as ESTA. Prosecutors Detail International Smuggling Operation According to court documents cited by the Justice Department, Lima-Santos conspired with others to operate an alien smuggling organization that promoted its services through multiple social media platforms. Federal prosecutors said the organization marketed both smuggling and fraudulent visa services to Cuban nationals and others seeking entry into the United States. One method involved helping Cuban nationals falsely claim European citizenship so they could attempt to enter the United States through the Visa Waiver Program using ESTA. Cuban nationals are not eligible for ESTA, according to the Justice Department. Prosecutors said members of the organization filed hundreds of fraudulent ESTA applications with U.S. Customs and Border Protection using fabricated documents and false addresses. Applications allegedly represented that individuals had not been in Cuba since 2011 even though prosecutors said they were physically in Cuba when their applications were submitted. The operation went beyond immigration paperwork. According to the Justice Department, Lima-Santos helped arrange transportation from countries of origin, including Cuba, into the United States. His activities included purchasing international and domestic airline tickets used to move people into and throughout the country. Lima-Santos Admits Role in Smuggling Five People Federal prosecutors said Lima-Santos and co-defendant Frandy Aragon-Diaz smuggled five people into the United States. Lima-Santos also admitted assisting Aragon-Diaz with bringing Cuban women illegally into the United States. According to the Justice Department, the women worked in strip clubs after arriving in the country to repay debts associated with their smuggling. The financial scale of the broader operation was also significant. Customers were charged between $1,500 and $40,000 for smuggling services, according to prosecutors. Members of the organization sometimes chartered private aircraft to transport groups. Prosecutors said Lima-Santos and his co-defendants regularly moved money to businesses and destinations outside the United States, including through transactions used to purchase international airline tickets. Between 2021 and 2024 alone, Lima-Santos transmitted more than $600,000 from the United States to international recipients to purchase flights for people entering the country unlawfully, according to the Justice Department. Shell Company Used to Move Money The money-laundering component of the case involved a Florida company that prosecutors characterized as a shell business. According to court documents, Lima-Santos filed articles of incorporation in Florida for a company that had no employees, payroll or reported income. Federal prosecutors said the company was nevertheless used to move money obtained from alien smuggling and conceal the source and nature of the proceeds. Florida corporate records also connect Lima-Santos to businesses in Tampa. State records identify him in management and registered agent roles associated with companies operating in the Tampa area. The financial transactions were part of the basis for the money-laundering charges to which Lima-Santos has now pleaded guilty. Twelve Defendants Charged in Federal Case Lima-Santos is one of 12 people charged in a superseding indictment announced by federal authorities in September 2025. The original indictment described an alleged multinational and multiyear operation involving alien smuggling, asylum fraud and money laundering. At the time, federal prosecutors alleged that defendants used a purported immigration-services business to facilitate fraudulent immigration filings and help move people into the United States. The 12 defendants named in the superseding indictment were Lazaro Alain Cabrera-Rodriguez, Yuniel Lima-Santos, Liannys Yaiselys Vega-Perez, Marianny Lucia Lopez-Torres, Frandy Aragon-Diaz, Erik Ventura-Castro, Miguel Alejandro Martinez Vasconcelos, Walbis Pozo-Dutel, Emanuel Martinez Gonzalez, Luis Emmanuel Escalona-Marrero, Layra Libertad Treto Santos and Gisleivy Peralta Consuegra. The case has progressed considerably since those charges were announced. The Justice Department said Thursday that Vega-Perez, Martinez Vasconcelos, Treto Santos, Martinez Gonzalez, Pozo-Dutel and Escalona-Marrero have pleaded guilty and are awaiting sentencing. Another defendant, Erik Ventura-Castro, pleaded guilty May 7 to conspiracy to commit alien smuggling for financial gain and conspiracy to launder monetary instruments. Ventura-Castro was sentenced in July to 30 months in federal prison. Prosecutors said Ventura-Castro transmitted more than $97,000 from the United States to the Cayman Islands, Colombia and Mexico to purchase airline tickets associated with unlawful entries into the United States. Two other defendants, Lazaro Alain Cabrera-Rodriguez and Gisleivy Peralta Consuegra, are awaiting trial, which is scheduled to begin Sept. 21, according to the Justice Department. The charges against defendants who have not pleaded guilty remain allegations, and they are presumed innocent unless and until proven guilty. Joint Task Force Alpha Leads Federal Effort The investigation was supported through Joint Task Force Alpha, the Justice Department initiative focused on major human smuggling and trafficking organizations. The Justice Department and Department of Homeland Security established the task force to combine federal investigative and prosecutorial resources against organizations involved in human smuggling and trafficking throughout the Americas. The Justice Department said the initiative has resulted in more than 477 domestic and international arrests of leaders, organizers and significant facilitators of smuggling or trafficking operations, along with more than 431 U.S. convictions and more than 370 significant prison sentences. The Tampa investigation was led by Homeland Security Investigations in Tampa, the U.S. Border Patrol's Miami Sector and U.S. Citizenship and Immigration Services' Fraud Detection and National Security Directorate. HSI's Human Smuggling Unit in Washington and Customs and Border Protection's National Targeting Center International Interdiction Task Force also provided assistance. Authorities in the Cayman Islands assisted federal investigators. Trial Attorney Amanda Brown of the Justice Department Criminal Division's Human Rights and Special Prosecutions Section and Assistant U.S. Attorney Courtney Derry for the Middle District of Florida are prosecuting the case. Lima-Santos Awaits Federal Sentencing Lima-Santos' guilty plea means the case against him now moves to the sentencing phase. Federal prosecutors said a sentencing hearing will be scheduled at a later date. Although the statutory maximum penalty is 20 years in prison, that does not mean Lima-Santos will necessarily receive a 20-year sentence. A federal district judge will determine the sentence after considering the advisory U.S. Sentencing Guidelines, the offenses of conviction, and other factors required under federal law. His plea adds another conviction to a federal prosecution that began with allegations against a dozen defendants and has produced a growing number of guilty pleas and at least one prison sentence. The Justice Department announced Lima-Santos' guilty plea on Aug. 13 as part of its continuing prosecution of the international smuggling and money-laundering operation. Read the full article

CHICAGO, IL - August 13, 2026 (STL.News) Cboe Global Markets, Inc. (CBOE) is increasing its quarterly dividend by 19%, extending a long-running record of annual dividend growth as the global exchange operator continues expanding its trading and market infrastructure businesses. The Chicago-based company announced Thursday that its board of directors declared a third-quarter 2026 cash dividend of $0.86 per share of common stock, up from the previous quarter's $0.72 per share. The increase represents an additional 14 cents per share each quarter, or approximately 19.4%, based on the previous payout. The new dividend will be paid on September 15, 2026, to Cboe shareholders of record as of the close of business on August 31, 2026. Perhaps more significant for long-term shareholders, Cboe said the increase marks the 16th consecutive year the company has raised its dividend. Cboe Dividend Rises to $3.44 Annualized At the new quarterly rate of $0.86 per share, Cboe's dividend would represent an annualized payout of $3.44 per share, assuming the company maintains the same quarterly distribution for four consecutive quarters. That compares with an annualized rate of $2.88 per share at the previous quarterly level of $0.72. The increase therefore adds 56 cents per share to the annualized dividend rate. For an investor holding 100 Cboe shares, the new quarterly dividend would be $86, compared with $72 at the previous rate. On an annualized basis, the difference would be $56 for every 100 shares held, assuming no further changes to the dividend. Dividend declarations remain subject to board approval each quarter, meaning the annualized figure should not be interpreted as a guaranteed future payment. Sixteen Years of Dividend Growth The latest increase continues Cboe's lengthy dividend-growth record. Cboe paid a quarterly dividend of $0.72 per share during the first quarter of 2026. The company announced that dividend in February, with payment made March 13 to shareholders of record February 27. The decision to raise the payout to $0.86 represents a substantial step higher rather than a minor adjustment and reinforces Cboe's history of returning capital to shareholders. For income-oriented investors, consecutive annual dividend increases can be an important measure of a company's willingness and financial ability to return cash to shareholders. Dividend growth can also provide another component of shareholder returns beyond changes in the market price of the underlying stock. Cboe Entered 2026 After Record Results The dividend increase follows a strong 2025 financial performance for Cboe Global Markets. In February, the company reported record full-year net revenue of $2.4 billion, representing 17% growth over the previous year. Cboe also reported record full-year diluted earnings per share of $10.42, an increase of 45%. Adjusted diluted earnings per share reached a record $10.67, up 24% for the year. Fourth-quarter 2025 net revenue totaled $671.1 million, an increase of 28% from $524.5 million during the comparable quarter a year earlier. Fourth-quarter diluted EPS reached a record $2.97, up 60%, while adjusted diluted EPS increased 46% to a record $3.06. Those results reflected strength across Cboe's operations, particularly its derivatives business. The company said derivatives net revenue increased 38% in the fourth quarter compared with the fourth quarter of 2024, supported by record volumes across index and multi-listed options. Cash and Spot Markets net revenue increased 27%, while Cboe Data Vantage net revenue rose 9%. Cboe Continues Expanding Market Access Cboe has also been pursuing initiatives intended to expand access to U.S. markets. Earlier this year, the company received approval from the Securities and Exchange Commission to offer extended trading hours for certain multi-listed single-stock options. The initiative was designed to introduce pre-market and post-market sessions for qualifying equity options, extending investors' ability to respond to corporate announcements and other market-moving developments outside traditional trading hours. Cboe has also outlined plans to expand U.S. equities trading as global demand for greater access to American markets continues to grow. Those efforts fit into the company's broader position as one of the world's major operators of trading markets and financial-market infrastructure. From Options Exchange to Global Markets Operator Cboe traces its history to the launch of the Chicago Board Options Exchange in 1973, which the company describes as the world's first listed options exchange. Over subsequent decades, the organization expanded far beyond its original options-market roots. Cboe has been closely associated with several major innovations in derivatives markets, including S&P 500 Index options and the Cboe Volatility Index, better known as the VIX. The VIX has become one of the world's most widely followed measures of expected stock-market volatility. Today, Cboe operates across derivatives, equities and foreign-exchange markets and provides trading, clearing, data and investment-related solutions to customers around the world. Its operations extend across North America, Europe and the Asia-Pacific region. That diversification means Cboe's financial performance can be influenced by a combination of trading volumes, market volatility, transaction fees, clearing activity, market data and other services. Dividend Increase Adds to Shareholder Returns Thursday's announcement does not change Cboe's underlying business strategy, but it represents a tangible increase in the amount of cash the company plans to distribute to shareholders. Moving from $0.72 to $0.86 per quarter is particularly notable because it represents a nearly 20% increase in a single step. Investors evaluating the dividend will nevertheless need to consider the payout alongside Cboe's earnings, cash generation, capital requirements, growth investments and share valuation. Dividend yield also changes as CBOE's stock price moves, meaning the percentage yield available to investors can fluctuate even when the dollar dividend remains unchanged. The company's 16-year record of annual increases, however, provides a longer-term measure of Cboe's dividend history. For existing shareholders, the immediate dates to watch are August 31, the record date, and September 15, when the third-quarter dividend is scheduled to be paid. With the quarterly payment increasing to $0.86 per share, Cboe enters the second half of 2026 with a higher shareholder distribution and another year added to its consecutive dividend-growth record. Disclaimer: This article is for news and informational purposes only and does not constitute investment, financial, or trading advice. Investors should conduct their own research and consult qualified financial professionals before making investment decisions. Read the full article

LOS ANGELES, CA - August 13, 2026 (STL.News) The U.S. Department of Justice has settled with the Los Angeles County Sheriff's Department in a federal lawsuit challenging lengthy delays in processing concealed carry weapon permits, ending a case the government brought over alleged violations of applicants' Second Amendment rights. The Justice Department announced the settlement Thursday, saying the Los Angeles County Sheriff's Department has agreed to bring its firearm carry permit procedures in line with the U.S. Supreme Court's landmark New York State Rifle & Pistol Association v. Bruen decision. According to the DOJ, applicants were waiting an average of more than nine months when the federal government filed its lawsuit in September 2025. The department said LASD has since substantially reduced its processing times and is now complying with applicable statutory deadlines. The resolution follows an unusual federal civil rights case involving the Second Amendment. When the lawsuit was filed, the Justice Department described it as its first affirmative lawsuit brought in support of gun owners seeking concealed carry permits. DOJ challenged lengthy Los Angeles permit delays The dispute arose after the Justice Department opened an investigation into LASD's concealed carry permitting practices on March 27, 2025. Federal officials said the investigation followed complaints concerning delays experienced by people applying for concealed handgun licenses. DOJ ultimately reviewed information involving thousands of applications before filing its complaint in the U.S. District Court for the Central District of California on September 30, 2025. The federal complaint named the Los Angeles County Sheriff's Department and Sheriff Robert Luna, in his official capacity, as defendants. The numbers contained in that complaint illustrated the scope of the dispute. LASD received approximately 3,982 applications for new concealed carry licenses between January 2, 2024, and March 31, 2025, according to information the Sheriff's Department provided to federal investigators. As of May 8, 2025, DOJ alleged that only two licenses had been issued from that group and two applications had been denied. Approximately 2,768 new applications remained pending, while another 1,210 had been withdrawn for various reasons. Federal officials alleged that applicants experienced an average delay of 281 days before LASD advanced an application to the next step, with a median delay of 372 days. The longest recorded period cited in the complaint was approximately 1,030 days between the receipt of an application and the next step occurring or being scheduled. Some interviews were scheduled as far out as November 2026. Those figures represented allegations made by the federal government in its complaint and should not be interpreted as separate judicial findings against LASD. California law establishes permit deadlines. The lawsuit focused not only on the Second Amendment but also on California's statutory timetable for processing concealed carry applications. According to the federal complaint, California law requires licensing authorities to provide an initial determination on a completed new-license application within 90 days. The complaint also cited state law requiring written notice of final approval or denial within 120 days of receipt of a completed application or 30 days after receipt of specified information from the California Department of Justice, whichever is later. DOJ argued that the lengthy delays documented during its investigation went far beyond those requirements. The department filed its case under the Police Pattern or Practice Act, 34 U.S.C. § 12601, which authorizes the federal government to seek equitable relief involving patterns or practices by law enforcement officers that deprive people of federally protected rights. LASD adds personnel and processing software The dispute appears to have changed significantly after the federal lawsuit was filed. In announcing the settlement Thursday, DOJ said LASD devoted additional resources to addressing the permit backlog, including more personnel and new processing software. Assistant Attorney General Harmeet K. Dhillon of the Justice Department's Rights Division said Sheriff Luna acknowledged the problem and committed substantial resources to reducing processing times. "The sheriff acknowledged the problem and devoted substantial additional resources, including new processing software and additional personnel, to cutting waiting times dramatically," Dhillon said in the DOJ announcement. DOJ said the changes have "drastically" reduced waiting times and brought the department into compliance with statutory deadlines. The Los Angeles County Sheriff's Department currently provides an online system for initial and renewal concealed carry applications. Its CCW information page directs eligible applicants to the online application process. Bruen decision changed the concealed carry landscape. The settlement also requires that LASD's procedures conform to the Supreme Court's decision in New York State Rifle & Pistol Association v. Bruen. In that case, the Supreme Court held that the Second and Fourteenth Amendments protect an individual's right to carry a handgun outside the home for self-defense. The decision invalidated New York'sYork'srement that applicants demonstrate a special need for carrying a firearm beyond the needs of the general public. The ruling had nationwide implications for jurisdictions that previously gave government officials substantial discretion over whether an applicant had demonstrated sufficient cause to receive a carry license. California subsequently continued operating a licensing system while adjusting its laws and procedures to the constitutional requirements established by the Supreme Court. The Los Angeles case raised a different but related issue: whether excessive administrative delays could effectively prevent otherwise qualified applicants from exercising a constitutional right even when a permitting system formally allowed them to apply. DOJ alleged that the delays amounted to a pattern or practice of depriving applicants of their Second Amendment rights. Settlement ends significant Second Amendment case. The agreement represents a significant conclusion to a case that marked a new direction in federal Second Amendment enforcement. The Justice Department's Rights Division traditionally handles cases involving constitutional and federal civil rights protections across a broad range of areas. In March 2025, the department announced its investigation into LASD's practices, followed six months later by the federal lawsuit. Less than a year after that complaint was filed, DOJ says the processing problems at the center of the litigation have been substantially corrected. The department characterized Thursday's settlement as a victory for Los Angeles County residents and Second Amendment rights. For concealed carry applicants, the most immediate significance is practical. If LASD continues meeting California's processing deadlines, residents seeking permits should no longer face the extraordinary waiting periods described in the federal government's complaint. The settlement does not mean every applicant is entitled to receive a concealed carry permit. Applicants remain subject to California's eligibility, investigation, training, and other lawful licensing requirements. The central issue in the federal case was whether qualified applicants were being subjected to delays that effectively prevented timely consideration of their applications. LASD remains responsible for administering the concealed carry licensing process within its jurisdiction. At the same time, the Justice Department's Civil Rights Division continues to accept complaints from current or prospective gun owners who believe a state or local government has infringed their right to keep or bear arms. The settlement closes a federal lawsuit that began with allegations of waits measured in months — and, in some cases, years — and concludes with DOJ saying the Los Angeles County Sheriff's Department has brought its processing times back within the deadlines established by law. Sources: U.S. Department of Justice, Civil Rights Division; federal complaint in United States of America v. Los Angeles County Sheriff's Department and Robert Luna, Case No. 2:25-cv-09323; U.S. Supreme Court; Los Angeles County Sheriff's Department. Read the full article

WASHINGTON, D.C. - August 13, 2026 (STL.News) DOJ - The U.S. Department of Justice (DOJ) announced Thursday that it has reasonable cause to believe California's corrections system and two state women's prisons are violating the U.S. Constitution by failing to adequately protect incarcerated women from sexual abuse and harassment by staff. The findings involve the California Department of Corrections and Rehabilitation, or CDCR, the Central California Women’s Facility in Chowchilla and the California Institution for Women in Chino. Federal investigators described a longstanding pattern of staff sexual misconduct accompanied by inadequate safeguards, problems with confidential reporting, deficient investigative practices and insufficient accountability. The Justice Department (DOJ) concluded that the systemic deficiencies violate prisoners' rights under the Eighth and Fourteenth Amendments. The department also found that CDCR and the two facilities have failed to adequately and effectively implement requirements of the federal Prison Rape Elimination Act, commonly known as PREA. The findings mark a significant escalation of a federal civil rights investigation that began nearly two years ago and could ultimately lead to litigation against California if state officials fail to implement sufficient reforms. DOJ Investigation Finds Longstanding Pattern The Justice Department's (DOJ's) 31-page findings report said investigators examined allegations of sexual misconduct dating back to 2000 and found what they described as an "unbroken pattern" of sexual misconduct by staff extending from 2000 through 2024 and continuing into the present. Importantly, the federal findings are not based solely on allegations made by prisoners. DOJ said CDCR itself has repeatedly sustained allegations of staff sexual abuse at the two facilities, meaning the state's own investigative process determined that misconduct occurred. Despite being aware of the risks, federal investigators concluded that CDCR and prison officials failed to take adequate measures to deter and detect sexual misconduct and hold responsible employees accountable. "Female prisoners have the constitutional right to be free from sexual assault and harassment by prison staff," Assistant Attorney General Harmeet K. Dhillon of the Justice Department's Civil Rights Division said in announcing the findings. Dhillon said the investigation found that CDCR knew about repeated incidents of sexual assault and harassment and failed to adequately protect incarcerated women. Hundreds of Misconduct Allegations Reviewed The scope of the allegations documented by investigators is substantial. According to California's own records cited in the federal findings report, prisoners made more than 375 allegations of staff sexual misconduct at the two women's prisons between 2023 and June 2025. Federal investigators reviewed more than 350 prisoner allegations involving sexual misconduct by staff. The report also said 320 private lawsuits have been filed, primarily by former prisoners, against CDCR and the two institutions. The investigation included reviews of policies, procedures, staffing records, training materials, misconduct logs and investigative files. Federal investigators also examined court proceedings involving sexual misconduct allegations against California and its employees and contractors. Investigators conducted a three-day onsite review at the Central California Women's Facility in May 2025 and another three-day assessment at the California Institution for Women in July 2025. They interviewed prisoners and employees, toured housing units and work programs, and worked with two expert consultants specializing in correctional operations and prisoner sexual safety. The Justice Department noted that California officials cooperated with the investigation. Two Major California Women's Prisons The Central California Women's Facility is located in Chowchilla and is California's largest women's prison. According to the DOJ report, it housed 2,189 prisoners as of July 29, 2026, and covers approximately 640 acres. The California Institution for Women in Chino housed 1,124 prisoners as of the same date and covers approximately 120 acres. The federal investigation began on Sept. 4, 2024, under the Civil Rights of Institutionalized Persons Act, or CRIPA. When announcing the investigation, DOJ pointed to hundreds of private lawsuits alleging sexual abuse at the Chowchilla facility and a lawsuit involving 21 women incarcerated at the Chino prison. Allegations cited at the time ranged from inappropriate touching during searches to forcible sexual assault. The investigation also examined whether reporting systems and institutional practices discouraged prisoners from reporting misconduct. The 2026 findings report describes concerns about the confidentiality of complaints, including instances in which employees allegedly accessed information involving grievances filed against them. Investigators said weaknesses in the reporting and investigative systems could discourage prisoners from making complaints because they feared allegations would not remain confidential. DOJ Orders Corrective Measures The Justice Department has now formally notified California of minimum corrective measures it says are necessary to remedy the constitutional violations. Those measures include expanded surveillance-camera coverage, improved confidential reporting channels, stronger investigative procedures, enhanced staff training and monitoring, and safeguards that comply with PREA. Federal officials stressed that the findings require action rather than simply additional study. "California owes a legal and moral duty to safeguard prisoners in its custody," First Assistant U.S. Attorney Bill Essayli for the Central District of California said. Essayli said the report should serve as a "turning point" for addressing persistent failures involving sexual abuse at the facilities. U.S. Attorney Eric Grant for the Eastern District of California similarly urged swift compliance with the remedial measures outlined by federal investigators. DOJ - California Has 49 Days to Address Findings California now faces a significant deadline. The Justice Department said that if state officials do not satisfactorily address the identified problems within 49 days, the U.S. Attorney General may initiate litigation under CRIPA. That does not mean the Justice Department has already filed a lawsuit against California. Thursday's announcement represents the findings of a federal civil rights investigation and formal notice to the state of alleged constitutional violations and required corrective measures. DOJ said it intends to work cooperatively with California in seeking remedies. The distinction is important: the department's determination is a federal investigative finding that there is reasonable cause to believe systemic constitutional violations exist. It is not a final judgment issued by a court. However, the findings substantially increase the legal pressure on California. If federal and state officials cannot reach an acceptable resolution, CRIPA gives the Justice Department authority to pursue the matter in federal court. For California, the next 49 days will determine whether the findings lead to negotiated reforms or escalate into federal civil rights litigation over conditions inside two of the state's women's prisons. Read the full article

BILOXI, MS - August 13, 2026 (STL.News) Ground Zero Biloxi LLC, operator of the Ground Zero Blues Club in Biloxi, Mississippi, has agreed to pay $35,000 and provide other relief to settle a federal lawsuit alleging sexual harassment and retaliation against a former assistant manager, according to the U.S. Equal Employment Opportunity Commission. The EEOC announced the settlement Wednesday, Aug. 12, resolving litigation that accused the music venue and restaurant of failing to protect an assistant manager from alleged sexual harassment by one of the company's co-owners and later firing her after she reported the conduct. The federal agency's allegations included repeated unwanted sexual comments and physical contact. The settlement resolves the lawsuit without requiring the allegations to be decided at trial. EEOC alleged harassment by company co-owner According to the EEOC, one of Ground Zero Biloxi's co-owners allegedly subjected the assistant manager to repeated sexual comments and unwelcome physical contact. The agency further alleged that company managers failed to protect the employee from the co-owner's conduct. The assistant manager reported the alleged harassment to the company's chief financial officer, according to the EEOC. The EEOC said the company subsequently fired the assistant manager in September 2023. Federal regulators alleged that the termination constituted retaliation for reporting the alleged harassment. The allegations ultimately led the EEOC to file a federal lawsuit against Ground Zero Biloxi LLC on June 5, 2025. The original lawsuit described the alleged behavior as a continuing campaign that included unwanted sexual comments and multiple instances of unwanted physical contact. The agency said the employee repeatedly complained, but no effective action was taken to stop the alleged conduct. The EEOC also alleged that the employee was terminated shortly after submitting written complaints about the co-owner to the company's chief financial officer. Federal lawsuit followed unsuccessful conciliation The case was filed as EEOC v. Ground Zero Biloxi LLC, Case No. 1:25-cv-00173-TBM-RPM, in the U.S. District Court for the Southern District of Mississippi. Before filing an employment discrimination lawsuit against a private employer, the EEOC generally conducts an administrative process that may include attempts to resolve the dispute voluntarily. In this case, the EEOC said it filed the lawsuit after first attempting to reach a pre-litigation settlement through its administrative conciliation process. When the lawsuit was originally announced in June 2025, the agency said it was seeking back pay, compensatory and punitive damages, and injunctive relief intended to prevent similar alleged conduct in the future. More than a year after the complaint was filed, the parties have now reached a settlement. Ground Zero Biloxi will pay $35,000 and provide additional relief under the resolution announced by the EEOC. EEOC points to employer responsibility Marsha Rucker, regional attorney for the EEOC's Birmingham District, emphasized employers' responsibilities to prevent and address sexual harassment. “Employers are responsible for preventing and remedying sexual harassment in their businesses,” Rucker said in announcing the settlement. Rucker also noted the power imbalance that can exist when an alleged harasser is a business owner, saying such circumstances can leave employees without an effective internal remedy. The case highlights an important issue for restaurants, bars, entertainment venues and other businesses where an owner or senior manager may work directly alongside employees. Title VII not only prohibits certain forms of workplace discrimination. Federal law also protects workers from retaliation for opposing conduct they reasonably believe violates anti-discrimination laws or for participating in certain protected processes. Acting EEOC Birmingham District Director Linda Sales-Long said employees must be able to exercise those rights without facing retaliation. “Standing up against sexual harassment at work takes courage to defend your rights,” Sales-Long said. She added that the EEOC is prepared to act when an employer retaliates against a worker for defending those rights. Title VII at center of Ground Zero case The EEOC brought its claims under Title VII of the Civil Rights Act of 1964, one of the nation's principal federal employment discrimination laws. Title VII prohibits employment discrimination based on race, color, religion, sex, and national origin. Sexual harassment can constitute unlawful sex discrimination when the conduct meets the applicable legal standards. Federal law also prohibits retaliation against employees for engaging in protected activity, including opposing unlawful employment discrimination. In the Ground Zero Blues Club case, the EEOC's lawsuit combined both issues: alleged sexual harassment and alleged retaliation after the assistant manager complained. The settlement means those allegations will not have to proceed through a trial to reach a resolution. Importantly, a settlement should not be characterized as a judicial finding that every allegation in the EEOC's complaint was proven. The agency's descriptions of the alleged conduct are allegations made as part of the federal enforcement action, and the resolution of the case should be distinguished from a court verdict following a trial. EEOC continues enforcement in hospitality industry The Ground Zero case is one of several recent EEOC enforcement actions involving allegations of harassment and retaliation in restaurants and hospitality-related businesses. Federal regulators have repeatedly emphasized that owners, managers and supervisors are subject to workplace anti-discrimination requirements and that employers need effective procedures for employees to report harassment. The EEOC's Birmingham District Office has jurisdiction over Alabama, most of Mississippi and the Florida Panhandle. The EEOC is the federal agency responsible for enforcing federal laws prohibiting employment discrimination by covered private-sector employers. It investigates discrimination charges, attempts to resolve certain disputes, and can bring litigation when the agency determines legal action is warranted. For employers, the Ground Zero settlement serves as another reminder that responding to a harassment complaint can be as legally significant as preventing the underlying conduct. An employer facing a complaint must consider both the substance of the allegation and federal protections against retaliation. For employees, the case illustrates that federal anti-discrimination protections extend beyond prohibiting workplace harassment itself. Workers who report alleged discrimination or harassment may also have legal protection against retaliatory employment actions. Ground Zero Biloxi LLC's $35,000 settlement brings the federal lawsuit filed in 2025 to a conclusion, following the EEOC's allegations stemming from the assistant manager's employment and September 2023 termination. The settlement resolves the litigation while avoiding a trial over the EEOC's allegations. Read the full article

HOUSTON, TX - August 13, 2026 (STL.News) Microvast Holdings, Inc. (NASDAQ: MVST) is facing a federal securities class action alleging the battery technology company and certain executives made materially false or misleading statements concerning its expected profit margins, business conditions, and the timing of an expansion at its manufacturing operations in Huzhou, China. The lawsuit, Graham v. Microvast Holdings, Inc. et al., was filed July 21, 2026, in the U.S. District Court for the Southern District of Texas. The case is No. 4:26-cv-05804 and covers investors who purchased or otherwise acquired Microvast securities between April 1, 2025 and March 16, 2026, inclusive. Investors seeking appointment as lead plaintiff have until September 21, 2026 to file a motion with the court. The lawsuit remains in its early stages. Its claims are allegations, and the filing of a complaint does not establish that Microvast or any individual defendant committed securities fraud or violated federal securities laws. Lawsuit Targets Microvast Statements The complaint alleges that Microvast and certain company officials made materially false or misleading statements or failed to disclose material information concerning the company's business, operations, and prospects during the class period. A central issue is Microvast's ability to achieve previously discussed gross-margin targets. The plaintiff alleges that inventory management problems and delays in customers' commercial vehicle rollouts affected Microvast's ability to achieve its expected margins. The litigation also challenges representations concerning the company's ability to complete its Huzhou Phase 3.2 expansion by the end of 2025. According to the complaint, the plaintiff contends that these circumstances made certain public statements concerning Microvast's outlook materially false or misleading. Microvast and the other defendants will have an opportunity to challenge those allegations as the case proceeds. MVST Shares Fell 34.2% One of the most significant events in the alleged disclosure timeline came in March 2026. Microvast reported financial results for the fourth quarter and full year ended Dec. 31, 2025, on March 16. The results revealed a sharp deterioration in fourth-quarter gross margin and included impairment charges involving specialized energy-storage-system components. According to litigation notices, Microvast reported fourth-quarter revenue of approximately $96.5 million, while gross margin fell to approximately 1%, compared with roughly 36% in the comparable quarter a year earlier. The following trading day, March 17, 2026, Microvast shares dropped $0.79, or 34.2%, closing at $1.52 per share. That decline is a significant component of the plaintiff's case because securities plaintiffs generally must connect alleged corrective disclosures to investor losses. A large stock decline alone, however, does not establish securities fraud. Share prices can fall for many reasons, and the plaintiff must ultimately establish the legal elements required under federal securities law. Huzhou Expansion Included in Allegations Microvast develops battery technologies for commercial vehicles and energy-storage applications. Its manufacturing capacity and ability to expand production are therefore important considerations for investors evaluating the company. The complaint specifically addresses the company's Huzhou Phase 3.2 expansion. According to summaries of the allegations, Microvast had discussed plans involving production from the expansion by the end of 2025. The plaintiff alleges that the company overstated its ability to complete the expansion within that timeframe. The lawsuit, therefore, extends beyond one disappointing quarterly earnings report. It concerns statements made during an approximately one-year class period involving margins, operational performance, and manufacturing capacity. Those allegations have not been adjudicated. Federal Lawsuit Names Company Executives The case is captioned Leah Graham v. Microvast Holdings, Inc. and was filed in the Southern District of Texas. Court and litigation records identify Microvast and certain company officials as defendants. The lawsuit alleges violations of federal securities laws, including provisions commonly used in securities fraud actions involving alleged material misrepresentations or omissions. Under federal securities law, plaintiffs generally must prove considerably more than a stock-price decline. Depending on the particular claim, issues can include whether a statement or omission was material, whether the required state of mind existed, whether investors relied on the alleged misrepresentation, and whether the alleged conduct caused an economic loss. Those questions will be addressed through the litigation unless the case is dismissed, settled, or otherwise resolved. September 21 Lead Plaintiff Deadline Investors who acquired Microvast securities during the April 1, 2025 through March 16, 2026 class period have until September 21 to seek appointment as lead plaintiff. The deadline has prompted numerous securities litigation firms to issue shareholder notices. A lead plaintiff generally represents the interests of the proposed investor class and works with counsel in directing the litigation. Importantly, an investor generally does not have to become lead plaintiff to potentially participate in a recovery if a class is eventually certified and the investor otherwise qualifies. Multiple firms publicizing the litigation have specifically emphasized that distinction. The federal court determines who will serve as lead plaintiff and ultimately addresses the appointment of lead counsel. Law Firms Involved in Microvast Investor Outreach Numerous securities and shareholder-rights firms have issued notices concerning the Microvast case, announced investigations or solicited investors who may have suffered losses. The distinction is important: a firm advertising the Microvast lawsuit is not necessarily counsel of record in the federal case or court-appointed class counsel. Public notices reviewed in connection with the case identify firms including: - Pomerantz LLP - The Rosen Law Firm, P.A. - Levi & Korsinsky, LLP / SueWallSt - Faruqi & Faruqi, LLP - Robbins LLP - The Law Offices of Frank R. Cruz - Bronstein, Gewirtz & Grossman, LLC - The Gross Law Firm - Wolf Haldenstein Adler Freeman & Herz LLP - Bragar Eagel & Squire, P.C. - Kirby McInerney LLP - Holzer & Holzer, LLC - Kessler Topaz Meltzer & Check, LLP - Kaplan Fox & Kilsheimer LLP Recent notices confirm that Kaplan Fox & Kilsheimer is also alerting investors to the pending action and September 21 deadline. Kessler Topaz Meltzer & Check maintains a case page that identifies the Southern District of Texas action, class period, and deadline. Bronstein, Gewirtz & Grossman likewise states that a class action has already been filed and that investors have until September 21 to request appointment as lead plaintiff. The Gross Law Firm has issued repeated deadline notices concerning the litigation. This list represents firms identified through publicly available case pages and investor notices reviewed as of August 13, 2026. Other firms may also investigate claims or issue shareholder notices before the September deadline. Investors should distinguish among the attorneys who filed or appear in the underlying federal action, firms seeking potential participation in the litigation, and firms independently advertising to prospective class members. This Is a Filed Lawsuit, Not Just an Investigation Another important distinction is that the Microvast matter has moved beyond the investigation stage. The federal securities class action was filed July 21, 2026. Case information identifies the U.S. District Court for the Southern District of Texas, case No. 4:26-cv-05804, and a proposed class period beginning April 1, 2025, and ending March 16, 2026. That means investors encountering advertisements stating that a law firm is "investigating" Microvast should understand that an underlying securities class action is already pending. Whether that lawsuit ultimately succeeds is a separate question. Microvast Has Faced Separate Securities Litigation Microvast has also been involved in an earlier securities class action, but investors should not confuse that litigation with the newly filed Graham case. Records identify a separate Microvast securities case filed in December 2023, with an earlier class period. That litigation arose from different allegations and events. The newer case filed in July 2026 covers the period from April 1, 2025 through March 16, 2026 and focuses on allegations involving margins, inventory issues, customer rollout delays and the Huzhou Phase 3.2 expansion. Litigation records separately identify the December 2023 and July 2026 Microvast cases, underscoring that they are distinct proceedings. What Happens Next The next major date for investors is September 21. Investors seeking to serve as lead plaintiff must move the court by that deadline. If multiple investors or investor groups apply, the court will determine which applicant is most appropriate to represent the proposed class under federal securities law. The defendants may challenge the complaint through motions to dismiss. Such motions are common in securities litigation and can test whether the complaint contains sufficiently particularized allegations to proceed. If the case survives preliminary challenges, it could move into discovery, potentially involving company records, internal communications, financial information, depositions and expert testimony. The court may later be asked to determine whether the proposed investor class should be certified. The case could also be settled, dismissed or otherwise resolved without a trial. At this stage, investors should not assume any particular outcome. What the Case Means for MVST Investors The Microvast litigation illustrates why the distinction between a disappointing corporate result and actionable securities fraud is important. Companies regularly miss forecasts, encounter production delays, or experience margin pressure without violating securities laws. For the plaintiff to prevail, the case must ultimately establish the elements required for the asserted securities claims. Microvast and the individual defendants are entitled to contest the allegations, challenge the plaintiff's evidence, and present their defenses. The March 17 stock decline nevertheless makes the case noteworthy for MVST shareholders. A 34.2% one-day decline represents a substantial loss of market value and provides the lawsuit with a clearly identifiable market event around which the plaintiff is attempting to establish investor damages. The litigation will now test whether that loss can legally be connected to alleged prior misrepresentations or omissions. Investors Have Options Shareholders seeing repeated advertisements from securities law firms should understand that they are not required to contact every firm publicizing the lawsuit. The September 21 deadline primarily concerns investors who want to ask the court to appoint them as lead plaintiff. According to multiple law-firm notices, an investor does not need to seek lead-plaintiff status to potentially share in a future recovery if the case ultimately produces one and the investor qualifies as a member of the class. There is also no guarantee of a recovery. No settlement has been announced, no damages award has been entered, and the allegations against Microvast have not been proven. Microvast Case Remains in Early Stages For now, several key facts are established: a federal securities class action has been filed against Microvast and certain company officials; the proposed class period runs from April 1, 2025 through March 16, 2026; the action is pending in the Southern District of Texas; and investors seeking appointment as lead plaintiff face a September 21, 2026 deadline. The underlying allegations center on Microvast's margin expectations, operational issues, and the timing of its Huzhou manufacturing expansion. The company's March 2026 financial disclosure and subsequent 34.2% decline in MVST shares provide the principal market event highlighted by firms publicizing the litigation. What remains unresolved is the central legal question: whether Microvast or the individual defendants violated federal securities laws. That determination will depend on the evidence, legal arguments, and future rulings in the federal case. Disclosure: This article is for news and informational purposes only and does not constitute legal, investment, or financial advice. The claims described above are allegations that have not been proven in court. The filing of a lawsuit does not establish liability, and no recovery for investors is guaranteed. Read the full article

ST. LOUIS, MO - August 13, 2026 (STL.News) Federal authorities have launched a new violent crime enforcement surge in St. Louis, bringing additional agents, investigators, analysts, and federal resources into the city as part of a coordinated effort led by the Bureau of Alcohol, Tobacco, Firearms and Explosives. The Department of Justice-sponsored operation began this week and is being led by ATF in close coordination with the U.S. Attorney’s Office for the Eastern District of Missouri. The St. Louis Metropolitan Police Department is participating alongside the FBI, Drug Enforcement Administration, Homeland Security Investigations, U.S. Marshals Service and other federal, state and local law enforcement agencies. The operation represents another significant federal commitment of law enforcement resources to St. Louis in 2026, following earlier initiatives that resulted in hundreds of arrests across the metropolitan area. Unlike a short-term sweep built around a predetermined number of arrests, however, the latest initiative is being described by federal authorities as an intelligence-driven operation focused on individuals and criminal networks believed to be responsible for shootings, illegal firearms trafficking and other violent crimes. ATF officials said the agency is targeting repeat violent offenders, people prohibited by law from possessing firearms and those suspected of supplying firearms illegally to individuals who use them to commit crimes. “Every part of this surge is aimed at one outcome: lasting public safety,” Bernard Hansen, special agent in charge of ATF’s Kansas City Field Division, said in announcing the operation. Hansen said the effort is intended not only to hold violent offenders accountable but also to disrupt criminal organizations and interfere with illegal firearms supply networks. He emphasized that investigators intend to follow evidence and develop prosecutable cases capable of having an impact beyond individual arrests. ATF brings additional federal resources to St. Louis Federal officials have not disclosed exactly how many additional agents and other personnel have been assigned to St. Louis. ATF said releasing the number could compromise operational security. The agency also declined to identify specific investigative targets, enforcement tactics, arrests or firearms seizures connected with the new operation while investigations remain underway. The agency said verified results will be released when doing so will not jeopardize investigations or court proceedings. That means residents could see increased federal law enforcement activity without immediately receiving a complete accounting of the cases being developed. The additional resources include more than agents on the street. The operation is bringing together investigators, intelligence analysts and prosecutors while making extensive use of federal firearms intelligence capabilities. ATF specializes in investigating firearms trafficking, illegal firearms possession and the use of firearms in violent crimes. Those capabilities can be particularly important when local police recover firearms or spent cartridge cases at crime scenes, and investigators need to determine whether a weapon or ballistic evidence is connected with other shootings. The agency stressed that the initiative is directed at violent criminal activity and the illegal supply of firearms to violent offenders. Law-abiding firearms owners and lawful firearms ownership are not targets of the operation, ATF said. St. Louis police working with federal agencies St. Louis Metropolitan Police Chief Robert J. Tracy welcomed the additional federal assistance, describing the operation as an opportunity to reinforce crime-reduction efforts already underway in the city. “Strong partnerships make stronger neighborhoods,” Tracy said. The chief said combining federal resources with local policing allows investigators to concentrate resources where they can have the greatest impact while continuing the city's existing public safety efforts. “This partnership is ultimately about the people we serve—helping families feel safe in their neighborhoods, supporting the officers working to protect them and continuing to build safer, stronger communities across our city,” Tracy said. The partnership is important because violent crime investigations frequently extend beyond the boundaries of one police jurisdiction. A firearm recovered in St. Louis could have been purchased elsewhere, passed through multiple individuals or connected to crimes committed in several jurisdictions. A suspect sought by city police could be living outside St. Louis. A criminal organization could operate across city, county and state lines. Federal agencies can combine intelligence from those jurisdictions while using federal investigative authorities and federal prosecutors when appropriate. U.S. attorney promises focus on downtown and crime hot spots U.S. Attorney Thomas C. Albus said his office will support the operation and specifically identified downtown St. Louis and violent crime hot spots as areas receiving attention. Albus said cooperation among federal, state and local law enforcement has produced results in St. Louis for decades and welcomed additional ATF agents and resources during the summer, when violent crime historically can increase. The U.S. Attorney’s Office for the Eastern District of Missouri will work with the St. Louis Circuit Attorney’s Office and Missouri Attorney General’s Office as part of the effort, Albus said. The involvement of federal prosecutors can significantly affect the trajectory of certain firearms and violent crime investigations. Cases involving prohibited persons possessing firearms, firearms trafficking, and other violations of federal law may be prosecuted in U.S. District Court rather than—or in addition to—proceedings under Missouri law, depending on the facts of individual cases and prosecutors' decisions. The announcement does not mean every person arrested during the operation will face federal prosecution. Investigations could result in federal charges, state charges or other enforcement actions depending on the evidence and applicable laws. Ballistics intelligence at center of operation A major component of the new initiative involves ATF's National Integrated Ballistic Information Network, commonly known as NIBIN. Agents, police officers, analysts, and prosecutors will combine locally developed information with ballistic leads generated through NIBIN and data obtained through crime gun tracing. NIBIN gives law enforcement agencies the ability to compare ballistic evidence recovered from crime scenes with evidence generated when recovered crime guns are test-fired. The technology can help investigators identify potential connections between shootings that initially appear unrelated. For example, cartridge cases recovered from separate crime scenes can contain markings that provide investigators with leads suggesting the same firearm may have been used in multiple incidents. That does not replace traditional investigative work. Instead, it can provide a starting point for investigators trying to understand whether different shootings, suspects or locations are connected. ATF said combining NIBIN information with crime gun tracing and traditional investigative techniques can help authorities identify shooters, associates, firearms traffickers and potential sources of crime guns. Crime gun tracing can reveal firearms supply chains Crime gun tracing serves a different but complementary purpose. When authorities recover a firearm associated with a crime, ATF can trace its commercial history from the manufacturer or importer through its first retail sale. Investigators can then use that information with other evidence to determine how a firearm may have moved from lawful commerce into the possession of someone prohibited from owning it or into a criminal network. A trace by itself does not establish that the original purchaser committed a crime. Firearms can change possession legally or illegally after an initial retail transaction. But when investigators identify patterns involving multiple firearms, repeated purchasers, common addresses or other connections, tracing information can become part of a broader investigation into suspected trafficking or straw purchasing. ATF reported in July that it had handled nearly 950,000 firearm trace requests nationally since January 2025 and that nearly 11,000 law enforcement agencies were receiving firearms tracing services from the agency. That national infrastructure is now being combined with local intelligence as authorities attempt to identify the people and networks responsible for gun violence in St. Louis. ATF has increased focus on violent crime The St. Louis operation follows a broader change in ATF enforcement priorities. In July, ATF reported that since January 2025 the agency had arrested more than 10,000 offenders and seized more than 49,000 firearms as part of an enforcement strategy focused on violent crime, transnational criminal organizations and illegal firearms pipelines. The agency also reported seizing approximately 2.9 million rounds of ammunition and 31,000 illegal explosives during that period. ATF said its participation in Homeland Security Task Force investigations contributed to those totals. The agency reported involvement in more than 1,200 HSTF investigations nationwide. For fiscal 2026, ATF said Homeland Security Task Force activity involving its personnel had resulted in more than 1,300 arrests, 200 indictments, 380 convictions and the seizure of approximately 3,000 firearms. More than $18 million in cash and monetary assets had also been recovered, according to the agency's July report. ATF's fiscal 2025 statistics provide another indication of the scale of its firearms enforcement responsibilities. The agency reported initiating 22,885 firearms cases during the fiscal year. It recommended prosecuting 8,052 firearms cases, while 5,545 were indicted and 4,061 resulted in convictions. ATF cautions against calculating direct indictment or conviction percentages from those figures because cases can move between stages across different fiscal years. St. Louis has already seen major federal operations in 2026 The latest ATF-led surge does not arrive in isolation. Federal agencies have carried out several major coordinated operations in the St. Louis region during 2026, demonstrating a growing emphasis on combining federal resources with local law enforcement. One of the most significant was Operation VIPER, an FBI-led initiative conducted from April 20 through May 1. That two-week operation resulted in 91 arrests across the St. Louis region. Authorities also recovered 36 firearms, three vehicles and approximately $310,000 in cash while seizing cocaine, methamphetamine and fentanyl. The operation included cooperation with law enforcement agencies in St. Louis, St. Louis County, St. Charles County and Jefferson County. Federal officials said the targets included fugitives and individuals connected with investigations involving violent crime, illegal firearms trafficking and drug trafficking. Operation VIPER demonstrated the potential impact of concentrating federal and local resources on a relatively small number of suspected offenders believed to be responsible for serious crimes. The new ATF-led initiative appears to build on the same general principle while placing additional emphasis on firearms intelligence, gun trafficking and the networks supplying weapons to violent offenders. Operation Patriot Shield resulted in 224 arrests Another major regional operation followed in June. Operation Patriot Shield, led by the U.S. Marshals Service and its task force partners, resulted in the arrests of 224 fugitives in Missouri and Illinois during the month. Authorities said the initiative cleared 290 outstanding felony arrest warrants. The types of cases involved illustrate the overlap among violent crime, firearms and narcotics investigations. According to the Justice Department, approximately 31% of the warrants were associated with narcotics charges, 28% involved weapons offenses and at least 20% involved violent crimes, including homicide. Deputy U.S. Marshals and task force partners also seized 32 firearms along with fentanyl, heroin, methamphetamine and marijuana. Sixteen people arrested in Illinois and six arrested in Missouri were linked to gangs, according to federal authorities. Deputies also located three missing children during the operation. The operation covered both sides of the Mississippi River, highlighting the regional nature of law enforcement challenges in metropolitan St. Louis. Why federal-local cooperation matters in St. Louis St. Louis sits at the center of a metropolitan region divided among numerous law enforcement jurisdictions. The city has its own police department. St. Louis County contains dozens of municipal police departments in addition to county law enforcement. Nearby counties have their own agencies, while the metropolitan area extends across the Mississippi River into southwestern Illinois. Criminal investigations do not necessarily respect those boundaries. Suspects, firearms, narcotics and vehicles can move between jurisdictions quickly. A shooting in St. Louis could have investigative connections to people or firearms in St. Louis County or elsewhere in Missouri or Illinois. Federal agencies provide another layer of jurisdiction and investigative capability. The FBI brings expertise in violent crime, gangs and federal criminal investigations. DEA focuses on drug trafficking organizations. The U.S. Marshals Service specializes in locating fugitives and executing high-risk warrants. Homeland Security Investigations investigates a range of transnational criminal activity. ATF brings specialized expertise involving firearms, explosives, arson and crime gun intelligence. The U.S. Attorney’s Office can then evaluate investigations for possible federal prosecution. The new St. Louis surge is designed to place those capabilities within a coordinated structure, rather than having agencies work independently on cases that may be connected. Firearms remain central to violent crime investigations ATF's leadership of the operation places firearms investigations at the center of the federal strategy. Authorities are not simply seeking to confiscate guns. The stated objective is to determine who is using firearms to commit violent crimes, who is illegally supplying those firearms, and whether individual shootings can be connected to broader criminal networks. That distinction matters. A recovered firearm can potentially generate several investigative paths. Its serial number may allow investigators to trace its commercial history. Ballistic testing may connect it to previous shootings. Interviews and other evidence can identify people who possessed or transferred the weapon. Digital evidence, surveillance video, and other investigative techniques can then be combined with the firearms intelligence. When investigators discover that multiple crime guns have common sources or connections, what began as a single firearms recovery can potentially develop into a trafficking investigation. ATF says its goal is to disrupt those supply chains rather than merely recover individual firearms after crimes have occurred. Recent case underscores danger facing investigators The announcement comes only days after federal prosecutors disclosed a case involving gunfire directed toward St. Louis police officers and ATF personnel. The U.S. Attorney’s Office for the Eastern District of Missouri announced Aug. 10 that two people were accused in connection with a July 28 incident in St. Louis in which officers and agents were conducting a traffic stop when another vehicle stopped roughly a block away, and someone fired 12 shots with what prosecutors described as an automatic weapon. Charges in criminal complaints and indictments are allegations. Defendants are presumed innocent unless and until proven guilty in court. The incident nevertheless illustrates the risks faced by officers and federal agents involved in firearms and violent crime investigations. Federal prosecutors have pursued significant gun cases ATF and the U.S. Attorney’s Office have also continued prosecuting firearms cases originating in the region. In July, U.S. District Judge John A. Ross sentenced a St. Louis gang leader and convicted felon to 200 months in prison in a case involving illegal gun sales to an undercover ATF agent and the robbery of that agent. Federal prosecutors said the defendant illegally sold firearms to the undercover agent before arranging the robbery. That case illustrates another element of ATF's work that could play a role in the new surge: longer-term investigations designed to identify networks and build cases rather than relying exclusively on immediate street arrests. Enforcement surge comes amid improving crime trends The new federal operation also begins against a different backdrop than St. Louis has faced during some previous violent crime initiatives. The city has reported significant improvements in several crime categories. St. Louis recorded 140 homicides during 2025, according to police figures reported earlier this year, representing the city's lowest annual homicide total in 12 years. Overall Part I crime declined approximately 16%, while shooting incidents were down 28% compared with 2023. Those improvements are important context for understanding the latest federal operation. The deployment is not being presented as a response to a sudden collapse in public safety. Instead, officials are describing it as an attempt to build on progress while concentrating additional resources on offenders and criminal networks that continue to generate gun violence. Chief Tracy specifically referred to building on the progress already underway in St. Louis during the discussion of the partnership. Summer months remain a concern U.S. Attorney Albus also pointed to the timing of the initiative. Summer has traditionally been a period when authorities prepare for potentially elevated levels of violence, and Albus said the additional ATF personnel and resources are welcome during those months. The operation beginning in August gives federal and local authorities an opportunity to focus resources during the remaining summer period while potentially developing cases that extend well beyond it. Because the initiative is intelligence-driven, its effects may not be measured solely by arrests made during the first days or weeks. Investigations into firearms trafficking and criminal networks can take time, particularly when authorities are attempting to identify suppliers, associates and connections among multiple incidents. Downtown St. Louis will receive attention Albus' explicit reference to downtown St. Louis is also notable. The U.S. attorney said his office would give special attention to downtown and violent crime hot spots as it supports the surge. Downtown public safety has implications extending beyond residents who live there. The area contains major employers, restaurants, entertainment venues, hotels, government offices and some of the region's most recognizable attractions. It also hosts large numbers of visitors to Cardinals and Blues games, concerts, conventions, and other events. Public perceptions of safety can therefore influence tourism, business investment, employment and the broader economic health of the city's core. The federal announcement did not identify individual downtown locations or neighborhoods that will be targeted. Read the full article

NEW YORK - August 13, 2026 (STL.News) U.S. Stock Market Today - U.S. stocks finished Thursday mostly higher as technology and semiconductor shares pushed the S&P 500 to a fresh record during the session, while softer producer inflation strengthened expectations that the Federal Reserve will leave interest rates unchanged at its September meeting. The S&P 500 closed at 7,781.59, gaining 33.09 points, or 0.43%. The Nasdaq Composite finished at 26,741.66, up about 0.58%, while the Dow Jones Industrial Average declined 96.14 points, or 0.18%, to 53,674.13. The S&P 500 reached an all-time intraday high of 7,816.70 before surrendering some of its gains late in the session. U.S. Stock Market Snapshot Major Index Closing Level Point Change Percent Change S&P 500 7,781.59 +33.09 +0.43% Nasdaq Composite 26,741.66 +153.17 +0.58% Dow Jones Industrial Average 53,674.13 -96.14 -0.18% Russell 2000 Above 3,060 intraday — Record high intraday The major indexes told two somewhat different stories Thursday. The S&P 500 and Nasdaq benefited from another strong technology rally, while the Dow was held back largely by Cisco Systems. Small-cap stocks also participated, with the Russell 2000 climbing above 3,060 to a new record during the session. U.S. Stock Market Today - S&P 500 reaches another record The S&P 500's move above 7,800 marked another milestone for a market that has continued to climb despite concerns about valuations, inflation, interest rates and geopolitical risks. The benchmark reached 7,816.70 at its session high before pulling back during afternoon trading. Even with the late retreat, the S&P 500 ended solidly higher and remained close to record territory. The index is now up nearly 14% in 2026, while the Nasdaq has gained approximately 15% this year, according to Reuters. Market participation was also broader than simply a handful of mega-cap technology companies. Advancing S&P 500 stocks outnumbered decliners by approximately 1.8 to 1, while the index registered 28 new highs against only one new low. The Nasdaq recorded 138 new highs and 74 new lows. That breadth provided additional support for Thursday's rally and suggested investors remained willing to take on equity-market risk. U.S. Stock Market Today - Inflation report gives Wall Street a boost Thursday's most important economic report arrived before the opening bell. The U.S. Bureau of Labor Statistics reported that the Producer Price Index for final demand was unchanged in July on a seasonally adjusted basis. Producer prices had declined 0.1% in June after increasing 0.5% in May. Prices for final-demand services increased 0.2% in July, while prices for final-demand goods declined 0.7%. Energy played a significant role in the decline in goods prices, with gasoline prices falling 5.7%. The relatively subdued headline reading helped ease concerns that the Federal Reserve would need to raise interest rates again at its September policy meeting. Following the report, traders were assigning roughly a 63% probability that the Federal Reserve will leave interest rates unchanged in September, according to Reuters, citing CME FedWatch data. Treasury yields also eased following the inflation data, providing another supportive factor for equities, particularly technology and other growth stocks whose valuations are sensitive to interest-rate changes. U.S. Stock Market Today - Semiconductor stocks power technology rally Technology was at the center of Thursday's advance. Memory-chip maker Sandisk surged approximately 16%, while Micron Technology gained about 6.7%. Broadcom rose roughly 1.3%, while Meta Platforms advanced about 2.8%. The continued enthusiasm surrounding artificial intelligence infrastructure has supported semiconductor stocks as investors assess the enormous capital expenditures directed toward data centers, cloud computing and AI systems. Recent forecasts from technology giants, including Microsoft and Amazon, have helped ease concerns that the industry's aggressive spending on AI infrastructure is slowing. The semiconductor rally was particularly important because many of Thursday's strongest technology performers are represented in the S&P 500 and Nasdaq but not in the Dow Jones Industrial Average. That difference helped produce the noticeable divergence between the major indexes. U.S. Stock Market Today - Cisco weighs heavily on the Dow The Dow's 96-point decline did not necessarily indicate broad weakness among blue-chip stocks. Cisco Systems fell approximately 9% after the networking equipment company issued an upbeat revenue forecast that nevertheless failed to meet investors' elevated expectations. Because the Dow is price-weighted, Cisco's decline had an unusually large effect on the index. Cisco's drop was responsible for roughly 64 points of downward pressure on the Dow at one stage Thursday, accounting for about two-thirds of the blue-chip index's decline. Meanwhile, semiconductor winners such as Sandisk and Micron are not Dow components, meaning the Dow received little direct benefit from some of the session's strongest technology stocks. The result was a market in which the S&P 500 reached a record while the Dow finished in negative territory. U.S. Stock Market Today - Small-cap stocks reach record territory Another significant development Thursday came from smaller U.S. companies. The Russell 2000 climbed above 3,060 during the session, setting a new record high. The small-cap benchmark has gained more than 23% so far in 2026, according to Benzinga. Strength in small caps can be particularly important for assessing the health of a broader market rally. For much of the AI-driven advance in U.S. equities, investors have questioned whether gains were concentrated too heavily among a relatively small group of mega-cap technology companies. The Russell's record provides evidence that investor demand is extending further into the market. U.S. Stock Market Today - Netflix rises while Tapestry tumbles Several individual stocks recorded large moves Thursday. Netflix gained approximately 3.7% after billionaire investor Bill Ackman's Pershing Square disclosed a new position in the streaming company as part of a substantial portfolio restructuring. Dell Technologies gained approximately 2.9%, while HP rose about 3.6% after China's Lenovo reported quarterly results that exceeded expectations. On the other side of the market, Tapestry plunged approximately 16% after the owner of Coach forecast sluggish annual revenue growth. The sharp reaction demonstrated that investors remain highly sensitive to corporate outlooks, particularly with major stock indexes trading near record levels. U.S. Stock Market Today - Oil prices retreat Energy prices provided another potentially positive development for the inflation outlook. Brent crude fell sharply during Thursday's session as investors assessed global demand, U.S. inventories and geopolitical developments. Reuters reported Brent trading around $87.66 per barrel, down approximately 1.5%, during the U.S. session. U.S. benchmark WTI crude was trading around $81.50 per barrel, down approximately 2.1%, while gold futures were near $4,415 an ounce during the session. Bitcoin traded around $63,000 to $63,500, remaining relatively subdued compared with the strength in equities. Lower energy prices are particularly important because sustained declines in crude oil prices can eventually reduce transportation and production costs, potentially easing some inflationary pressure. U.S. Stock Market Today - Wall Street turns toward Friday Thursday's session reinforced several of the major themes driving financial markets in 2026. Artificial intelligence investment continues to support semiconductor and technology stocks. Inflation remains a central concern, but July's flat producer price index reading gave investors additional reason to believe the Federal Reserve may be able to hold rates steady rather than tighten monetary policy further. At the same time, the Russell 2000 record suggests the rally is expanding beyond the mega-cap companies that have dominated market headlines. The S&P 500's move above 7,800 intraday will likely stand as Thursday's most significant market milestone. Although the index backed away from its high before the closing bell, it still gained 0.43% and finished at 7,781.59. The Nasdaq's 0.58% advance confirmed continued demand for technology shares, while the Dow's 0.18% decline largely reflected Cisco's outsized influence rather than broad market weakness. Investors now head into Friday watching Treasury yields, oil prices, corporate earnings and incoming economic data for additional clues about the Federal Reserve's September decision. With the S&P 500, Nasdaq and Russell 2000 at or near historic levels, Wall Street's central question is increasingly whether earnings growth and easing inflation pressures can continue supporting record equity valuations through the remainder of the summer. Disclaimer: This article is provided for news and informational purposes only and should not be considered investment, financial, or trading advice. Financial markets involve risk, and prices may change during after-hours and premarket trading. Read the full article

MEMPHIS, TN - August 13, 2026 (STL.News) — Former Regions Bank relationship banker Elazia Jones has been prohibited from participating in the banking industry after the Federal Reserve alleged she knowingly cashed counterfeit or fraudulent checks for personal benefits as part of a broader check-fraud ring that caused more than $396,000 in losses to Regions Bank. The Federal Reserve Board announced the enforcement action Thursday. Jones worked at Regions Bank's Hickory Ridge branch in Memphis before the bank terminated her employment on November 1, 2024, according to the regulator's Order of Prohibition. The order provides new details about the allegations against Jones but does not identify the other people allegedly involved in the broader fraud ring. Jones consented to the Federal Reserve's order without admitting or denying the allegations. The regulatory action should not be confused with a criminal conviction, and publicly available information reviewed by STL.News did not establish that Jones has been arrested or criminally charged in connection with the conduct described in the order. Fed alleges Elazia Jones cashed fraudulent checks According to the Federal Reserve, Jones was working as a relationship banker at the Hickory Ridge branch when the alleged conduct occurred. The regulator alleges that Jones knowingly cashed counterfeit or fraudulent checks and received personal benefits, including cash, in return. The Federal Reserve described the transactions as part of a broader check-fraud ring and said the scheme resulted in more than $396,000 in losses to Regions Bank. The order does not say that Jones personally received $396,000 or that she individually caused the entire loss. Rather, the regulator attributed losses exceeding that amount to the broader alleged check-fraud operation. That distinction is significant because the Federal Reserve's order does not identify the other alleged participants, disclose how many people were allegedly involved, or provide a transaction-by-transaction accounting of the losses. The order also does not disclose how much money or other benefits Jones allegedly received. Elazia Jones barred from participating in banking industry The Federal Reserve issued its Order of Prohibition under Section 8(e) of the Federal Deposit Insurance Act. Under the order, Jones is prohibited from participating in the affairs of an insured depository institution or certain other financial institutions without obtaining prior written regulatory approval. The restrictions extend beyond accepting another conventional banking job. Jones is prohibited from serving or acting as an institution-affiliated party — including as an officer, director or employee — at financial institutions covered by the order. She also faces restrictions on proxies, voting rights, and other forms of participation in the governance of covered financial institutions. The prohibition remains in effect unless the Federal Reserve expressly stays, modifies, terminates, or suspends it in writing. Violating the order could separately expose Jones to civil or criminal penalties under the Federal Deposit Insurance Act. Elazia Jones - Federal Reserve cites alleged personal dishonesty The Federal Reserve alleged that Jones' conduct constituted violations of law or regulation, unsafe or unsound banking practices, or breaches of fiduciary duty. The Board further alleged that the conduct involved personal dishonesty or willful or continuing disregard for Regions Bank's safety and soundness. Those are allegations contained in the regulatory enforcement proceeding. Jones agreed to the issuance of the prohibition order without admitting or denying the allegations and waived several rights that would otherwise have been available to her in a contested Federal Reserve enforcement proceeding. Among those were the right to a hearing to present and challenge evidence and the right to obtain judicial review of the order. The settlement allowed the Federal Reserve to impose the prohibition without conducting a formal adjudicatory proceeding on the underlying allegations. Elazia Jones - Hickory Ridge branch remains a Regions location The Regions Bank branch identified in the Federal Reserve order is the Hickory Ridge branch in Memphis. Regions currently lists the full-service branch at 5969 Winchester Road. Among its listed transaction services are deposits, cash withdrawals and check cashing. Jones' employment there ended with her termination on November 1, 2024, according to the Federal Reserve. Regions Bank is headquartered in Birmingham, Alabama, and operates as the principal banking subsidiary of publicly traded Regions Financial Corp. The bank operates across a substantial portion of the South, Midwest and Texas. The enforcement order concerns Jones individually. The Federal Reserve document does not accuse Regions Bank or Regions Financial Corp. of participating in the alleged check-fraud ring. Elazia Jones - Questions remain about broader check-fraud ring One of the most significant details in the Federal Reserve action is its description of Jones' alleged activity as part of a broader check-fraud ring. The order does not identify other alleged members of the operation. It also does not provide the dates on which the allegedly fraudulent checks were cashed, identify the customers or accounts involved, disclose the number or value of individual checks, or explain how Regions discovered the alleged activity. A review of publicly available information on Thursday did not locate a federal criminal case, Justice Department announcement, or other reliable public record establishing that Jones has been arrested, indicted, or convicted in connection with the conduct described by the Federal Reserve. Accordingly, the Federal Reserve enforcement action should not be characterized as an arrest or criminal prosecution. It also remains unclear from the prohibition order whether any other alleged participants in the broader check-fraud operation have faced criminal or regulatory action. Elazia Jones - Jones can return only with regulatory approval The prohibition represents a potentially long-term consequence for Jones' ability to work in banking. Unlike an employment termination that applies to a single institution, a Federal Reserve prohibition can prevent an individual from participating in the affairs of institutions covered by federal banking law. Jones would need prior written approval from the Federal Reserve — and potentially another federal financial institutions regulator when required — before engaging in activities prohibited by the order. The Board also retained its authority to enforce compliance with the prohibition. The Federal Reserve said it would not take any further action against Jones regarding the matters covered by the order, based on facts presently known to the Board. That provision does not prevent other federal or state agencies from taking their own action. For now, the publicly established action against Jones is the Federal Reserve's prohibition on banking. The case is identified as Federal Reserve Docket No. 26-033-E-I. Read the full article

WASHINGTON, D.C. - August 13, 2026 (STL.News) Regions Bank - The Federal Reserve Board has prohibited a former Regions Bank employee from participating in the banking industry after alleging she knowingly cashed counterfeit or fraudulent checks as part of a broader check-fraud ring that caused the bank more than $396,000 in losses. The Board of Governors issued an Order of Prohibition against Elazia Jones, a former relationship banker at Regions Bank's Hickory Ridge branch in Memphis, Tennessee. The order was issued upon Jones' consent under Section 8(e) of the Federal Deposit Insurance Act. According to the Federal Reserve order, Jones worked as a relationship banker at the Hickory Ridge branch until Regions terminated her employment on November 1, 2024. The regulator alleges Jones knowingly cashed counterfeit or fraudulent checks in exchange for personal benefits, including cash. The transactions were part of what the Federal Reserve described as a broader check-fraud ring responsible for losses exceeding $396,000 to Regions Bank. Federal Reserve imposes banking industry prohibition. The enforcement action significantly restricts Jones' ability to work for or participate in the affairs of federally regulated financial institutions. Under the order, Jones is prohibited, without prior written regulatory approval, from participating in the affairs of an insured depository institution, a holding company of an insured institution, and certain other financial organizations covered by federal banking law. The prohibition also prevents her from serving or acting as an institution-affiliated party, including as an officer, director, or employee, at institutions covered by the order. Jones is additionally prohibited from certain activities involving voting rights and proxies at covered financial institutions. The Federal Reserve's Office of Inspector General has described Section 8(e) removal and prohibition orders as an industry-wide remedy designed to protect the banking system by preventing individuals subject to such orders from participating in the affairs of insured depository institutions. The Jones order remains effective unless it is expressly stayed, modified, terminated, or suspended in writing by the Federal Reserve Board. Jones did not admit or deny the allegations. The consent order contains an important distinction concerning the allegations against Jones. Jones agreed to the enforcement action without admitting or denying the allegations made or implied by the Federal Reserve. The matter was settled before a formal proceeding, testimony, or adjudication of the factual and legal issues outlined in the order. By consenting, Jones waived several procedural rights, including the right to a hearing to take evidence concerning the matters in the order and the right to seek judicial review of the order. The order also states that Jones waived the right to challenge or contest its basis, issuance, terms, validity, effectiveness, or enforceability. Any violation of the prohibition could expose Jones to separate civil or criminal penalties under the Federal Deposit Insurance Act, according to the Federal Reserve. The Board's order is dated August 5, 2026. Federal Reserve cites personal dishonesty. In describing the basis for its action, the Federal Reserve alleged Jones' conduct constituted violations of law or regulation, unsafe or unsound banking practices, or breaches of fiduciary duty. The regulator further alleged the conduct involved personal dishonesty or willful or continuing disregard for the safety and soundness of Regions Bank. The prohibition does not necessarily prevent other federal or state authorities from taking separate action affecting Jones. However, the order states that the Federal Reserve will not take further action against Jones concerning matters addressed by the order based on facts presently known to the Board. The regulator retains authority to ensure compliance with the order and to enforce it. The Federal Reserve order itself does not announce criminal charges against Jones, and the enforcement action should not be characterized as a criminal conviction. Regions Bank is a major U.S. regional bank Regions Bank is headquartered in Birmingham, Alabama, and is the primary banking subsidiary of Regions Financial Corp. (NYSE: RF). Regions Financial is an S&P 500 company and one of the country's larger providers of consumer and commercial banking, wealth management and mortgage products and services. The company operates primarily across the South, Midwest and Texas. As of its second-quarter reporting period, Regions Financial reported approximately $161 billion in assets. The company said it operates more than 1,200 banking offices and more than 1,750 ATMs through Regions Bank. Regions reported second-quarter 2026 net income of $549 million and diluted earnings of 64 cents per share. Adjusted earnings were $583 million, or 68 cents per diluted share. The enforcement action announced by the Federal Reserve targets Jones individually, as a former Regions employee. The order does not accuse Regions Bank or Regions Financial Corp. of participating in the alleged check-fraud scheme. Order remains in force unless regulators change it Jones would need prior written approval from the Federal Reserve Board — and, when required, from another appropriate federal financial institution regulator — before engaging in activities prohibited by the order. That restriction extends beyond simply obtaining another job at a bank. It covers serving as an officer, director, or employee at covered institutions and participating in certain voting and governance activities. The Federal Reserve has used prohibition orders in other cases involving alleged misconduct by bank employees and executives. In May, for example, the Board announced a consent prohibition order against a former Commerce Bank employee for fraudulent customer transactions. The Jones case is listed as Docket No. 26-033-E-I. Unless the Federal Reserve subsequently issues a written order to stay, modify, terminate, or suspend the order, its provisions remain fully effective and enforceable. More business news articles that you might find interesting on STL.News: - ManhattanLife Acquires Union Security Life of New York - Overseas Markets Rise as Oil, Rates Drive Trading - NHC Declares Quarterly Dividend - US Stock Market Today – Thursday, August 6, 2026 - Undervalued Stocks: Where Value Investors Are Looking in 2026 Read the full article

ST. LOUIS, MO - August 13, 2026 (STL.News) The U.S. Equal Employment Opportunity Commission has sued Washington University in St. Louis, alleging the prominent private research university unlawfully retaliated against a former employee who complained about race discrimination connected to a mandatory diversity, equity and inclusion training session. The federal lawsuit centers on a former senior program manager at the Alvin J. Siteman Cancer Center, one of the St. Louis region's most prominent medical and cancer research institutions. According to the EEOC, the employee complained internally and later filed a discrimination charge with the federal agency before Washington University eliminated her position in November 2025. The allegations have not been proven in court, and the filing of a lawsuit does not constitute a finding that Washington University violated federal law. The EEOC announced the lawsuit Wednesday, Aug. 12. It was filed as EEOC v. The Washington University, Case No. 4:26-cv-01289, in the U.S. District Court for the Eastern District of Missouri. EEOC Alleges Retaliation After Employee Complained According to the EEOC's account, the employee worked as a senior program manager at Siteman Cancer Center when she participated in a mandatory training session provided by Washington University's Office of Diversity, Equity and Inclusion. The EEOC alleges the employee had expressed concern in advance about being separated from white colleagues on the basis of race during the training. According to the agency, she was nevertheless separated from colleagues during the session. She complained internally about the incident in January 2025, the EEOC said, and later filed a discrimination charge with the agency in July 2025. The lawsuit alleges that after those actions, supervisors transferred some of her job responsibilities to other employees. Washington University subsequently eliminated her position in November 2025, resulting in her termination, according to the EEOC. The agency contends those actions amounted to retaliation prohibited by Title VII of the Civil Rights Act of 1964. "Employees have the right to oppose and complain about race discrimination in all aspects of their employment, including training, without fear of retribution," acting EEOC General Counsel Catherine L. Eschbach said in announcing the lawsuit. Title VII Protects Employees From Retaliation Title VII prohibits employment discrimination based on race, color, religion, sex and national origin. The law also contains protections designed to prevent employers from retaliating against workers who oppose practices they reasonably believe are discriminatory or who participate in the discrimination-complaint process. That distinction is important to the Washington University case because the EEOC lawsuit focuses specifically on alleged retaliation following the employee's complaints. The federal agency alleges the employee engaged in legally protected activity by raising concerns internally and subsequently filing an EEOC charge. David S. Davis, director of the EEOC's St. Louis District, said federal protections extend to complaints made both within an employer's organization and through outside channels. Before filing the lawsuit, the EEOC said it attempted to resolve the matter through its administrative conciliation process. Those efforts did not produce a pre-litigation resolution, according to the agency. The EEOC's St. Louis District Office handles discrimination charges and agency litigation covering Missouri, Kansas, Oklahoma, Nebraska and part of southern Illinois. Washington University Has Deep St. Louis Roots The defendant is one of the most prominent educational, research and medical institutions in the St. Louis region. Washington University in St. Louis, commonly known as WashU, is an independent private research university founded in 1853 by St. Louis merchant Wayman Crow and minister and civic leader William Greenleaf Eliot Jr. The institution initially operated in downtown St. Louis before eventually relocating to what is now its Danforth Campus. Today, the university describes itself as a medium-sized independent institution with students and faculty from across the United States and more than 100 countries. It offers more than 250 academic programs and approximately 5,500 courses across undergraduate, graduate and professional disciplines. Its operations extend well beyond traditional higher education. WashU Medicine is a major component of the university and plays a significant role in medical education, scientific research and patient care throughout the St. Louis metropolitan area. The university also represents a substantial part of the regional economy. According to WashU's fiscal 2025 Community Impact Report, the institution employed 23,434 people, including 19,533 full-time employees, and estimated its total regional economic impact at $9.8 billion. The university said its activities supported more than 60,000 jobs throughout the region. Those figures make Washington University's employment practices particularly significant locally because the institution is not simply an educational campus but one of the region's largest employment and economic centers. Siteman Cancer Center Plays Major Medical Role The employee at the center of the EEOC case worked at the Alvin J. Siteman Cancer Center, which combines the cancer research, treatment and prevention programs of Barnes-Jewish Hospital and WashU Medicine. Founded in 1999, Siteman has developed into one of the region's most significant health care and medical research institutions. Siteman is the only cancer center in Missouri and southern Illinois with the National Cancer Institute's Comprehensive Cancer Center designation and an "Exceptional" rating, according to the center. The organization says more than 75,000 people receive care through Siteman annually, including approximately 12,000 newly diagnosed patients. Its medical and research operations include hundreds of WashU Medicine physicians and scientists and extensive cancer research programs. Siteman says its scientists and physicians receive more than $180 million annually in basic and clinical oncology research grants. The center also provides patients access to hundreds of clinical trials and operates facilities across the St. Louis metropolitan area and in Illinois. Siteman received the National Cancer Institute's Comprehensive Cancer Center designation in 2005. The NCI later awarded the center its highest "Exceptional" rating following reviews of its research programs. The prominence of both Washington University and Siteman means the EEOC lawsuit involves institutions with significant visibility in St. Louis and nationally within academic medicine. Lawsuit Now Moves Into Federal Court The EEOC's complaint begins the federal litigation process rather than resolving the underlying allegations. Washington University will have an opportunity to respond to the complaint and contest the government's allegations. The court could ultimately resolve the dispute through motions, settlement, or trial, depending on how the litigation develops. As of the EEOC's announcement, there had been no court determination that Washington University violated Title VII, and allegations contained in the government's complaint should not be interpreted as established facts. The EEOC is seeking remedies available under federal employment law. The agency's announcement emphasized its broader position that workers must be able to raise discrimination concerns without retaliation. The case could also draw attention beyond the immediate employment dispute because the employee's original complaint arose from a mandatory DEI training program. However, the central legal question presented by the EEOC is not a broad determination about DEI programs. The government's lawsuit alleges that Washington University retaliated against an employee after she opposed what she believed was racial discrimination and later filed an EEOC charge. That distinction is likely to remain important as the case moves forward. Washington University will have the opportunity to present its account of the events and defenses through the federal court process. For St. Louis, the lawsuit puts one of the region's largest and best-known institutions under federal scrutiny over allegations involving workplace discrimination complaints and retaliation. STL.News will continue monitoring EEOC v. Washington University for Washington University's formal response, significant court filings, settlement developments, or rulings from the U.S. District Court for the Eastern District of Missouri. Source: U.S. Equal Employment Opportunity Commission, Washington University in St. Louis and Alvin J. Siteman Cancer Center. Editor's Note: The allegations described in this report are allegations made by the EEOC in a federal civil lawsuit. Filing a complaint does not establish liability, and Washington University is entitled to contest the allegations in court. Read the full article